Study of PI3K protective actinos in Aβ42-induced neurodegeneration by Arnés Fernández, Mercedes
!
!
!
!
!
!
FACULTY!OF!SCIENCES!
DEPARTMENT!OF!MOLECULAR!BIOLOGY!
!
!
!
DISSERTATION!TITLE:!
!
STUDY!OF!PI3K!PROTECTIVE!ACTIONS!IN!Aβ426INDUCED!
NEURODEGENERATION!
!
by!
!
Mercedes!Arnés!Fernández!
!
!
!
!
!
May!2016!
!
!
!
STUDY&OF&PI3K&PROTECTIVE&ACTIONS&IN&Aβ426INDUCED&
NEURODEGENERATION&
!
by!
!
Mercedes!Arnés!Fernández!
B.Sc.!in!Biology!
B.!Sc.!in!Biochemistry!
!
!
A!dissertation!submitted!to!the!Faculty!of!Sciences!!
at!the!Autonomous!University!!of!Madrid!
in!partial!fulfillment!of!the!requirements!for!the!degree!of!!
Doctor!of!Philosophy!in!Molecular!Biosciences!
!
!
May!2016!
!
!
!
Supervisor:!Dr.!Sergio!Casas!Tintó!
CoKsupervisor:!Dr.!Ángel!José!Acebes!Vindel!
Advisor:!Dr.!Francisco!Zafra!Gómez!
!
!
!
Cajal!Institute!
CSIC!
!
SUMMARY'
'
In' this' thesis' we' aimed' to' evaluate' the' ability' of' PI3K' overexpression' to' induce'
synaptogenesis'in'a'pathological'context'where'synapses'are'degenerated'due'to'Aβ42'
accumulation.'In'addition'we'analyzed'the'mechanism'underlying'PI3K'actions'in'Aβ42'
affected' synapses,' and' the' overall' effects' that' synaptic' changes' have' from' a'whole'
organism'perspective.'Our'data'demonstrated'that'PI3K'activation'is'beneficial'in'Aβ42'
neurodegeneration'since'it'prevented'synapse'loss,'microtubule'dynamics'defects,'and'
locomotion'and'lifespan'reduction.'
Furthermore,'we'described'a'novel'effect'of'PI3K' in'Aβ'aggregation'that' induces'the'
generation'of'insoluble'deposit.'This'change'in'conformation'is'suggested'to'occur'due'
to'a'PI3K'mediated'phosphorylation'in'residue'SerK26'of'Aβ'backbone.'
Synaptogenic' and' aggregation' effects' of' PI3K' in' Aβ42' neurodegeneration' are' also'
reproduced'in'human'neuroblastoma'cells,'proving'that'both'actions'are'conserved'in'
humans,'and'suggesting' that' it' could'be'considered' for' future' therapeutic' studies' in'
AD.'
In' addition,' discovery'of' a' transient'neuronal' enhancer' activation'event' in' epithelial'
cells' during' early' development' in' Drosophila,' helped' us' uncover' new' Aβ42' toxic'
effects' in' nonKneuronal' cells.' In' epithelial' cells' Aβ' activated' apoptosis' and' induced'
Wnt'signaling'misregulation.'Both' in'epithelial'cells'and' in'neurosecretory'cells'Aβ42'
deleterious'effects'were'restored'by'PI3K.''
!
SUMMARY'(in'Spanish)'
'
En'esta' tesis'doctoral' se'estudia' la'habilidad'de'PI3K,' fosfatidilinositol@3'kinasa,'para'
inducir'sinapsis'en'un'contexto'patológico'donde'éstas'se'hallan'deterioradas'debido'a'
la'acumulación'tóxica'del'péptido'amiloide'Aβ42.'Además,'se'analiza'el'mecanismo'de'
acción'de'PI3K'en'las'sinapsis'afectadas'por'Aβ42,'y'los'efectos'que'se'producen'a'nivel'
de'organismo'completo'debidos'a'los'cambios'sinápticos.'Nuestros'datos'demuestran'
que'la'activación'de'PI3K,'y' la'en'general'de'la'ruta'de'señalización'sinaptogénica,'es'
beneficiosa'en'un'contexto'de'neurodegeneración'producido'por'Aβ42'ya'que'restaura'
la'pérdida'de'sinapsis,' los'defectos'causados'en'la'dinámica'de'los'microtúbulos,'y' la'
reducción'en'la'locomoción'y'la'esperanza'de'vida'de'los'organismos.'
Asimismo,'se'describe'un'efecto'novedoso'de'PI3K'sobre'la'agregación'del'β@amiloide,'
induciendo' la'generación'de'depósitos'más' insolubles,'y'por'tanto'menos'tóxicos.'Se'
sugiere'que'este'cambio'conformacional'ocurre'debido'a'la'fosforilación'de'PI3K'en'el'
residuo'Ser@26'del'péptido'Aβ.'
Los'efectos' sinaptogénicos'y'agregantes' causados'por'PI3K'en' la'neurodegeneración'
mediada'por'Aβ'también'son'reproducibles'en' las'células'de'neuroblastoma'humano'
(HT@SY5Y),' indicando'que'ambos'efectos'están'conservados'en'humanos'y'sugiriendo'
que' podría' ser' utilizado' en' estudios' terapéuticos' futuros' de' la' enfermedad' de'
Alzheimer.''
Por' último,' se' descubre' un' proceso' de' activación' transitoria' de' dos' enhancer'
neuronales'en'células'epiteliales'durante'el'desarrollo'temprano'en'Drosophila,'lo'que'
se'utilizó'para'identificar'un'efecto'tóxico'novedoso'de'Aβ42'en'células'no@neuronales.'
La'expresión'del'péptido'amiloide'activa' la'apoptosis'e' induce' la'desregulación'de' la'
vía'de'señalización'de'Wnt'en'células'epiteliales.'Ambos'efectos'deletéreos,'originados'
por' la' actividad' de' Aβ42,' son' restaurados' por' la' sobreexpresión' de' PI3K' tanto' en'
células'epiteliales'como'en'células'neurosecretoras.''
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ABBREVIATIONS"
"
"
"
α7/nAChR" α7"nicotinic"acetylcholine"receptors"
Aβ"" " Amyloid"beta"
Abl" " Abelson"kinase""
AD" " Alzheimer’s"Disease"
Akt" " Protein"kinase"B"
AP1" " Activator"protein"1"
APLP1" " Amyloid"precursor/like"protein"1"
APLP2" " Amyloid"precursor/like"protein"2"
APP" " Amyloid"Precursor"Protein""
Arm" " Armadillo"
AZs" " Active"zones"
BMP" " Bone"morphogenetic"protein"
BRP" " Bruchpilot"
Bsk" " Basket"
cAMP" " Cyclic"adenosine"monophosphate""
CaMKII"" Calcium/calmodulin/dependent"kinase"II"
CNS"" " Central"nervous"system"
cGMP" " Cyclic"guanosine"monophosphate"
CREB" " cAMP"response"element/binding"
CSF"" " Cerebrospinal"fluid"
Csp/3" " Caspase"3"
dda"" " Dendritic"arborization"dorsal"cluster"(sensory"neurons)"
EB1" " End/binding"protein"1"
EDTA" " Ethylenediamienetetraacetic"acid"
EEG" " Electroencephalography""
Elav" " Embrionic"lethal"abnormal"vision"
EphB2" " Ephrin/type"B2"receptor"
EphA4" " Ephrin/type"A4"receptor"
FoxO" " Forkhead"box"protein"
Gbb" " Glass"bottom"boat"
GFP" " Green"fluorescent"protein"
GFP/nLs" Green"fluorescent"protein"/"nuclear"localization"sequence""
GSK/3" " Glicogen/3"kinase"
G/TRACE" Gal4"technique"for"real/time"and"clonal"expression"
Hrp" " Horseradish"peroxidase"
JNK" " c/jun"kinase"
LTD" " Long/term"depression"
LTM" " Long/term"memory"
LTP" " Long/term"potentiation"
MAPK" " Mitogen/activated"protein"kinases"
2"
Mad" " Mothers"against"decapentaplegic"
Med" " Medea"
mGluR5" Metabotropic"glutamate/5"receptor""
MMSE""" Mini/mental"state"evaluation"
mTOR" " Mammalian"target"of"rapamycin"
NFTs"" " Neurofibrillary"tangles"
NMDAR" N/methyl"D/aspartate"receptor"
NMJs" " Neuromuscular"junctions"
PBS" " Phosphate"buffered"saline""
PCP" " Planar"cell"polarity"
PET" " Positron"emission"tomography"
pH3" " Phosphohistone"3"
PI3K" " Phosphoinositide/3"kinase""
PIP2" " Phosphatidylinositol"4,5/bisphosphate"
PIP3" " Phosphatidylinositol"(3,4,5)/trisphosphate"
PrP" " Prion"protein"
PS/1" " Presenilin"1"
PSD/95"" Postsynaptic"density"95"
p/tau" " Phosphorylated"tau"
PTEN" " Phosphatidylinositol/3,4,5/trisphosphate"3/phosphatase"
RAGE" " Receptor"for"advanced"glycation"end/products"
RFP" " Red"fluorescent"protein"
RNAi" " Interference"RNA"
SDS" " Sodium"dodecyl"sulfate"
trkB" " Tropomyosin"receptor"B/"Tyrosine"receptor"kinase"B"
VLM" " Ventral"longitudinal"muscle"
Wit" " Wishful"thinking"
Wg" " Wingless"
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1.!NOW!AND!THEN!OF!ALZHEIMER’S!DISEASE!
Alzheimer’s"disease"was"first"described"in"1906"by"Alois"Alzheimer,"who"studied"the"brain"
of" a"51" years/old" female"patient" called"Augusta"D." She"had" suffered" from"memory" loss,"
hallucinations,"disorientation"and"paranoia,"and"had"later"died"because"of"the"injuries"of"a"
stay/in/bed"condition"and"a"pulmonary"infection."In"her"brain,"Alois"Alzheimer"described,"
the" two"hallmarks"of" the"disease," extracellular"β/amyloid"plaques" (Aβ)," and" intracellular"
neurofibrillary"tangles"(NFTs)."His"discoveries"were"presented,"at"the"37th"meeting"of"the"
Society" of" Southwest" Germany" Psychiatrists" in" Tübingen." At" that" time," this" type" of"
dementia"was"thought"to"be"a"rare"disease;"more"than"a"century"later,"Alzheimer’s"disease"
is" the" most" prevalent" neurodegenerative" illness" in" the" world," affecting" an" estimated"
population" of" 46"million" people" today." As" recently" published" by" the"World" Alzheimer’s"
Report" in" 2015," there" are" 10.5" million" patients" in" the" European" Union" and" 9.4" million"
patients"in"the"United"States"suffering"from"this"incurable"disease,"and"these"numbers"are"
estimated"to"double"every"20"years."The"global"incidence"extends"up"to"5%"of"people"over"
60"years"of"age,"being"2"in"3"women"patients.!
Known" by" being" the" most" common" type" of" dementia," Alzheimer’s" disease" (AD)" is"
characterized" by" a" progressive" neuronal" loss" that" causes" severe" cognitive" deficits" and"
neuropsychiatric" symptoms" which" induce" memory" loss," depression," anxiety," sleep"
alterations," hallucinations," aggressiveness" and" violence" among" other" symptoms" of"
neurodegeneration."The"diagnosis"of"patients"consists"in"the"proved"presence"of"amyloid/
β"and/or"tau" in"the"cerebrospinal"fluid"(CSF),"together"with"mini/mental"state"evaluation"
(MMSE)" for" cognitive" impairment"measure,"magnetic" resonance" imaging" (MRI)" for"brain"
volume"and"positron"emission"tomography"(PET)"scans"for"amyloid/β"plaques"and/or"brain"
glucose"metabolism"analysis.!
Although" the" presence" of" amyloid/β" and" phosphorylated" tau" (p/tau)" aggregates" is"
considered"to"be"the"main"sign"of"the"disease,"it"has"not"yet"been"clarified"if"those"are"the"
causing"agents"of"AD."Being"the"loss"of"memory"the"first"symptom"noticed"by"the"eventual"
patient,"it"is"very"intriguing"that"this"symptom"becomes"evident"only"2"or"3"decades"after"
amyloid/β"presence" is"determined" in"a"CSF"sample."Thus,"AD" is"a"complex,"multifactorial"
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syndrome"studied"nowadays"by"scientists"around"the"globe"to"understand"its"mechanisms"
aiming"to"find"ways"to"prevent"the"devastating"effects.!!
1.1!MULTIPLE!ETIOLOGIES!
95%"of"diagnosed"AD"cases"in"people"aged"60"or"older"are"thought"to"be"sporadic,"being"
aging" the"main" risk" factor." Taking" into" account" that"AD"develops"over" a" long"preclinical"
period,"the"question"arises"if"instead"of"a"causative"relation,"the"disease"can"progress"due"
to" accumulative" risk" factors" assessed" in" late" or"mid/life" before" the" onset" of" the" clinical"
symptoms."Many"studies"are"carried"out" to"decipher" if" factors"as"vascular"health"status,"
diabetes," obesity," physical" and" mental" inactivity," depression," smoking," low" educational"
level,"diet"or" toxic"environments"are" indeed" risk" factors"of"AD" (Selkoe"and"Hardy,"2015,"
Scheltens"et"al.,"2016).!
More"deeply"evaluated"risk"factors"include"genetic"factors"like"the"presence"of"the"allelic"
version"APOE4,"first"discovered"in"1993"(Corder"et"al.,"1993)"and"later"attributed"50%"risk"
for" AD" in" homozygous" individuals," and" 20/30%" for" APOE3" and" APOE4" heterozygotes"
(Genin" et" al.," 2011)."APOE4" is" a" lipoprotein" that"mediates" cholesterol"metabolism" in" an"
isoform/dependent" manner." The" variant" E4" associates" with" atherosclerosis," cognitive"
impairment," AD," faster" multiple" sclerosis" progression" and" telomeres" shortening." The"
ABCA7" lipid" transporter" has" been" identified" as" another" genetic" risk" factor" for" AD"
(Hollingworth" et" al.," 2011)." APOE4" and" ABCA7" alleles" are" associated" with" less" efficient"
amyloid/β" clearance," but" in" both" cases," more" evidence" needs" to" be" compiled" to"
understand"the"biochemical"details"of"their"contribution"in"AD"pathology.!
Microglial" elements" of" the" complement" cascade" have" recently" been" described" also" as"
genetic" risks:" CR1," CD33" and" TREM2" increase" expression" upon" amyloid/β" plaques"
formation" (Bertram"et" al.," 2008," Lambert" et" al.," 2009," Suarez/Calvet" et" al.," 2016)." Some"
other"endosomal"vesicle"recycling"elements"implicated"in"APP"(amyloid"precursor"protein)"
processing," like" SORL1," BIN1" and" PICALM," have" been" similarly" associated" with" AD"
pathogenesis"(Rogaeva"et"al.,"2007,"Lambert"et"al.,"2013,"Zhao"et"al.,"2015)."!
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In" summary," all" these" factors" could"directly" or" indirectly" alter" amyloid/β"homeostasis" in"
late/onset" (previously" described" as" sporadic)" AD" patients," which" serves" as" a" proof/of/
concept" for" the" amyloid" hypothesis" as" the" mechanistic" process" underlying" Alzheimer’s"
disease,"that"will"be"addressed"below.!!
1.2!β<AMYLOID!PATHOPHYSIOLOGY!!
Dominantly" inherited" forms" of" AD" and" non/dominant" forms" of" AD" share" the" common"
hallmarks"of"the"disease,"β/amyloid"plaque"formation"and"neurofibrillary"tangles"(NFTs)"of"
hyperphosphorylated"tau"aggregates."CSF"detection"of"Aβ"is"the"earliest"biomarker"for"the"
disease,"followed"by"p/tau."Both"show"exponential"accumulation"in"the"clinical"progressive"
phase"of"the"disease,"being"Aβ"levels"the"biomarker"that"shows"a"faster"increment"in"CSF."
NFTs" were" discovered" in" 1986" (Grundke/Iqbal" et" al.," 1986)" and" described" to" be"
intraneuronal" fibrillar" aggregates" of" hyperphosphorylated" tau" protein." Tau" is" a"
microtubule/associated"protein"that,"upon"phosphorylation,"alters"microtubule"dynamics"
by"pathologically" increasing"their"stability,"and"as"a"consequence"leads"to"a" less"dynamic"
cytoskeleton" and" deficient" transport." Several" kinases" are" implicated" in"
hyperphosphorylation"of"tau,"including"GSK/3,"MAPK,"CaMKII"and"Akt."NFTs"are"not"only"a"
marker" of" Alzheimer’s" disease" but" also" a" hallmark" of" other" types" of" dementia" and"
neurodegenerative"diseases,"generally"referred"to"as"tauopathies.!
Aβ" peptide" is" the" only" exclusive" marker" of" AD" known" today." It" is" generated" from" the"
processing" of" the" full/length" amyloid" precursor" protein" APP," a" transmembrane" protein"
processed" in" two"sequential"proteolytic"cleavages"by"β"and"γ"secretases" (De"Strooper"et"
al.," 2010);" known" as" the" amyloidogenic" pathway." The" first" cleavage," mediated" by" β/
secretase,"generates"a"soluble"(sAPPβ)"fragment"and"a"βAPP/CTF"fragment."Subsequently,"
the" γ/secretase" produces" other" proteolytic" cut" upon" the" βAPP/CTF" that" leads" to" the"
formation"of"the"Aβ"fragment."This"Aβ"fragment"is"released"from"the"intracellular"domain"
of"APP"(AICD).""Two"forms"of"Aβ"of"40"or"42"aminoacids"can"be"produced"(Aβ40"and"Aβ42),"
but"it"is"the"relative"amount"of"Aβ42"what"is"critical"in"AD"progression.!
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In" contrast," APP" can" also" suffer" non/amyloidogenic" processing" when" it" is" first" cleaved"
inside"the"Aβ"sequence"by"the"α/secretase,"leading"to"a"soluble"(sAPPα)"fragment"and"the"
membrane/tethered"αAPP/CT"fragment,"that"can"be"then"proteolysed"by"the"γ/secretase"
and"give"rise"to"p3"and"AICD"fragments.!
It"is"important"to"note"here"that"the"amyloidogenic"proteolytic"pathway"of"APP"also"occurs"
under" non/pathological" conditions." Only" when" the" equilibrium" between" its" production"
through" amyloidogenic" processing" of" APP," and" its" degradation" by" neprilysin," insulin"
degrading" enzyme" or" endothelin" converting" enzyme" (Turner" et" al.," 2004)" becomes"
imbalanced,"Aβ"is"regarded"as"a"synaptotoxin,"and"the"amyloid"cascade"is"initiated"(Hardy"
and"Higgins,"1992).!
Once" generated," the" Aβ" peptide" can" accumulate," oligomerize" and" aggregate."
Furthermore," the" initial" Aβ" molecules" can" suffer" modifications" as" truncations,"
isomerizations" and/or" phosphorylations" that" affect" oligomerization" and" aggregation"
patterns"(Kummer"and"Heneka,"2014)."!
Aggregation*of*Aβ!
The"relative"increase"in"Aβ42/Aβ40"due"to"excessive"accumulation"of"β/amyloid"can"lead"
to" protein" aggregation," which" involves" a" misfolding" process" of" Aβ" into" soluble" and"
insoluble" assemblies." Aβ" innocuous" monomers" are" composed" by" α/helical" and/or"
unordered" structure," while" Aβ" polymers" have" β/sheet" conformation" that" promote"
homophilic" interactions"leading"eventually"to"toxic"oligomer"formation"(Pike"et"al,"1991).""
As" the" nucleation/dependent" polymerization" model" states," monomers" can" suffer"
conformational"changes"of"self/assembly"and"generate"oligomers"in"a"thermodynamically"
unfavorable" manner." The" resulting" oligomers" can" then" associate" and" create" oligomeric"
nuclei" that" elongate" and" assemble" larger" aggregates" in" a" more" favorable" and" rapid"
process."The"concentration"of"nuclei,"or"seeds,"is"crucial"for"determining"the"lag"phase"of"
aggregation." The" addition" of" seeds" would" reduce" the" lag" time" and" promote" faster"
aggregation"(Murphy"and"LeVine,"2010,"Goedert,"2015).!
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The"aggregation"process"is"thought"to"be"critical"for"AD"development"and"progression,"as"
the"different"Aβ"species"differ" in" toxicity" (Goure"et"al.,"2014)."Monomers"are" innocuous,"
but"as"they"self/associate" into"oligomers"and"pre/fibrillar"aggregates," they"become"toxic."
Insoluble"Aβ"plaques"are"now"considered"rather"benign"species"that"could"serve"as"a"sink"
but" also" a" potential" source" of" toxic" soluble" oligomers" (Caughey" and" Lansbury," 2003,"
Stefani,"2010,"Moreth"et"al.,"2013,"DaRocha/Souto"et"al.,"2011).!
Thus,"there"are"three"different"Aβ"pools"with"different"aggregation"kinetics"that"can"cause"
from" non/deleterious" effect" to" very" toxic" damage" to" cells." " From" a" biophysical" point" of"
view,"small"soluble"aggregates"could" induce"stronger"synaptotoxic"effects"as"they"have"a"
much"larger"surface"to"interfere"with"the"surrounding"cells"than"Aβ"insoluble"plaques.!
Being"the"soluble"species"the"most"neurotoxic"aggregates,"strong"effort"has"been"directed"
to" elucidate" whether" Aβ" is" accumulated" extracellularly," intracellularly" or" in" both"
compartments."!
The"amyloid"cascade"hypothesizes"that"plaques"can"sequester"Aβ"oligomers"until"reaching"
a" physical" limit" after" which" the" oligomers" diffuse" to" the" surrounding" membranes" and"
hydrophobic"cell"surfaces"(Esparza"et"al.,"2013)."!
Extracellular*and*Intracellular*β8amyloids!
First"and"direct"evidence"of"extracellular"Aβ"is"found"in"Aβ"measurements"of"CSF"analysis"
in" AD" patients" (Engelborghs," 2013," Goedert," 2015)." On" the" other" hand," intracellular"
accumulation"has"also"been"found"in"high/resolution"electron/microscopy"studies"in"brain"
samples" of" AD" patients," where" Aβ" appeared" inside" of" the" cell" at" synaptic/terminals"
(Gouras"et"al.,"2010)."!
Classical" extracellular" localization" of" Aβ" deposits" occurs" as" a" consequence" of" initial" APP"
amyloidogenic"proteolysis"by"β/secretase"cleavage" in"the"extracellular"domain."Next," the"
subsequent" cleavage" of" the" intramembranous" domain" by" γ/secretase" releases" the" Aβ"
peptide"into"the"extracellular"space"or"vesicle"lumen"(Shoji"et"al.,"1992,"Haass"et"al.,"2012)."
Intracellular" deposits" have" also" been" detected" in" several" studies" (Wirths" et" al.," 2004,"
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Crowther"et"al.,"2005,"LaFerla"et"al.,"2007,"Zhao"et"al.,"2010)."Their"nature"has"not"yet"been"
fully" clarified," as" they" could" be" a" result" of" endosomal" membrane/APP/derived" Aβ"
aggregates," or" they" could" be" on" the" process" of" secretion," targeted" for" lysosomal"
degradation"or"even"a"result"of"a"later"uptake"of"previously"secreted"Aβ"oligomers.!
Whether" the" first" toxic" source" of" oligomers" is" the" extracellular" β/amyloid" or" the"
intracellular"β/amyloid"is"a"question"still"under"debate."!!
1.3!Aβ<MEDIATED!SYNAPTOTOXICITY!
Aβ" oligomers" are" gradually" accumulated" in" limbic" and" association" cortices," where" they"
cause" subtle" effects" to" synapse" efficacy." Higher" deposition" of" oligomers" can" induce" the"
formation"of" diffuse"plaques" that" later"promote"microglial" and"astrocytic" activation" and"
inflammation."Together,"all" these"events" result" in"altered"neuronal" ion"homeostasis"and"
modified"kinase"and"phosphatase"activities"that"lead"to"NFTs"formation,"as"a"consequence,"
these"events"induce"a"widespread"neuronal"dysfunction"and"neuronal"loss"that"ultimately"
manifest"in"cognitive"impairment"and"dementia."!
Synaptotoxic*Effects*of*Aβ!
It" is" well" documented" that" Aβ" oligomers" produce" early" synaptic" alterations" that" later"
develop" into" dramatic" synapse" loss." Although" strong" efforts" have" been" directed" to" the"
study" of" the" mechanisms" by" which" β/amyloids" elicit" synaptotoxicity," it" is" still" today" a"
matter"of"deep"analysis,"as"it"seems"a"very"complex"sequence"of"events.!
LTP" (Long" Term" Potentiation)" and" LTD" (Long" Term" Depression)" electrophysiological"
recordings" of" synaptic" strength" and" plasticity" have" shown" interesting" results" upon" Aβ"
oligomer’s"exposure."They"measure"activity/dependent"reduction"of"efficacy"in"synapses"in"
NMDAR"(N/methyl"D/aspartate"receptor)"/dependent"long/term"potentiation"and"NMDAR/
dependent" long/term" depression," respectively." Several" studies" have" proved" that" Aβ"
impairs"LTP"(Walsh"et"al.,"2002,"Cleary"et"al.,"2005)"but"increases"LTD"(Hsieh"et"al.,"2006)"
causing" synaptic" depression." The"mechanisms"by"which"Aβ" enhances" LTD" are" still" to" be"
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completely" elucidated," but" they" comprise" receptor" internalization," desensitization" or"
activation"of"perisynaptic"receptors"that"lead,"eventually,"to"spine"loss."
Although"electrophysiological"recordings"have"highlighted"the"synaptotoxic"actions"of"Aβ,"
it" is" still" an" open"question"whether" they" act" in" specific" sets" of" cells" or" synapses" or" not."
Several" membrane" receptors" have" been" proposed" to" act" as" specific" targets" of" Aβ" in"
neurons:"NMDA"(De"Felice"et"al.,"2008,"Decker"et"al.,"2010),"the"prion"protein"(PrP)"(Lauren"
et"al.,"2009)," the"metabotropic"glutamate/5" receptor" (mGluR5)" (Renner"et"al,"2010)," the"
receptor" for" advanced" glycation" end/products" (RAGE)," the" neurotrophin" receptor" p75"
(Yaar"et"al.,"1997),"the"α7"nicotinic"acetylcholine"receptors"(α7/nAChR)"(Wang"et"al.,"2000,"
Dineley"et"al.,"2001),"the"postsynaptic"membrane"associated"protein"PSD/95"(Pham"et"al.,"
2010)," the" Ephrin/type" B2" receptor" (EphB2)" (Cisse" et" al.," 2011)" and" Ephrin/type" A4"
receptor" (EphA4)" (Vargas" et" al.," 2014)," and" Insulin" receptors" (Giuffrida" and"McMahon,"
2010),"among"others."None"of"them"has"been"found"to"be"necessary"and"sufficient"to"elicit"
Aβ"toxicity"(Benilova"et"al.,"2012)."!
Aβ*Effects*in*Neuronal*Networks!
Early"Aβ"synaptotoxicity"yields"to"progressive"degeneration"of"neuronal"tissue,"especially"
noticeable" in" the"entorhinal" cortex"and" the"hippocampus," regions" implicated" in" learning"
and"memory."!
Experimental"evidence"supports"that"Gabaergic"neurons"could"be"more"vulnerable"to"Aβ,"
and" that" β/amyloids" could" act" inhibiting" network" excitation" by" suppressing" synaptic"
transmission" strength"and" short/term"plasticity" (Palop"and"Mucke,"2010)." In" contrast," in"
vivo"studies"in"hAPP"(human"APP)"transgenic"mice"show"evidence"of"epileptic"activity"upon"
Aβ" exposure," in" EEG" recordings" from" cortex" and" hippocampus" (Palop" et" al.," 2007)."
Furthermore,"cell"culture"and"cortical"slices"have"shown"to"increase"their"activity"after"Aβ"
treatment" (Palop" et" al.," 2007)." These" results" suggest" that" Aβ" can" also" elicit" aberrant"
excitatory"changes"in"neuronal"circuits."This"fact"could"generate"a"positive"feedback"loop,"
as" an" increment" in" neuronal" activity" have" shown" to" produce" enhancement" of" Aβ"
production,"which"would"progressively"induce"abnormal"patterns"of"neuronal"activity."As"a"
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result,"this"feedback"loop"could"also"affect"compensatory"inhibitory"responses"that"would"
imply"learning"and"memory"circuits.!
Aβ"toxicity"affect"synapses"depending"on"its"own"abundance,"and"on"the"synapse"nature"
and" vulnerability" to"Aβ" (Palop"and"Mucke," 2010)."Moreover,"AD"progression"appears" to"
affect"different"processes"at"different"stages"of"the"disease.""!
1.4!EMERGING!HYPOTHESES!FOR!ALZHEIMER’S!
Growing" evidence" suggests" a" strong" association" between" insulin" signaling" components"
and"AD"pathogenesis,"this"relation"suggests"that"the"disease"could"develop"as"a"metabolic"
syndrome"where"the"patient"presents"insulin"resistance"or"deficiency."It"has"been"shown"
that"extracellular"Aβ"oligomers"are"able"to"impair"insulin"receptor"themselves"(De"Felice"et"
al.," 2008)." Intracellular" Aβ" can" interfere" with" phosphoinositide/dependent" kinase" (PDK)"
and"Akt"interaction,"affecting"insulin"receptor"signaling"by"inhibiting"Akt"activation"(Lee"et"
al.,"2009)."Also,"the"use"of"intranasal"insulin"in"clinical"trials"has"had"positive"results"(Craft"
et"al.,"2012),"as"well"as"the"use"of"a"diabetes"drug,"rosiglitazone,"that"is"able"to"lower"Aβ"
oligomers"levels"in"culture"and"rescues"synapses"and"plasticity"in"vivo"via"PPAR/γ"pathway"
(Xu"et"al.,"2014)."!
Insulin" signaling" impairment" could" furthermore" contribute" to" the" dysfunction" of"
downstream"pathways"including"PI3K,"Akt"and"Wnt/β/catenin"or"enhancement"of"GSK/3β"
activity,"triggering"tau"hyperphosphorylation.!
Multiple"Wnt"family"components"are"dysregulated"in"AD"and"have"been"implicated"in"the"
characteristic" cognitive" decline" and" synaptic" loss" (Inestrosa" and" Varela/Nallar," 2014)." β/
catenin" levels" are" reduced" in" mutated" PS/1" carrying" AD" brains" (Zhang" et" al.," 1998)" in"
addition"Dickkopf/1"(Dkk1),"an"endogenous"Wnt"inhibitor,"is"found"to"be"increased"both"in"
AD"brains"and"mouse"models"(Caricasole"et"al.,"2004,"Rosi"et"al.,"2010)"and"neuronal"death"
and"Aβ/induced"tau"phosphorylation"can"be"prevented"by"Dkk1"knockdown"(Caricasole"et"
al.,"2004).!
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Taken" together," all" these" data" suggest" that" dysregulation" of" insulin" and"Wnt/β/catenin"
pathways"contribute" to"Aβ/induced"synaptic" loss"and" their"components"could"constitute"
potential"therapeutic"targets"against"AD"progression"(Inestrosa"and"Varela/Nallar,"2014).!!
2.!MOLECULAR!TOOLS!FOR!SYNAPTOGENESIS!
The"search"for"new"tools"to"restore"the"loss"of"synapses"in"neurodegenerative"diseases"has"
been" very" intense" in" the" last" years." In" particular," synapse" maintenance" is" critical" for"
delaying" the" loss" of" spines" and" synaptic" function" that" occurs" along" the" normal" ageing"
process.!
Protein" kinases" are" involved" in" plasticity" mechanisms" like" neurogenesis," modulation" of"
intrinsic"excitability,"long/lasting"strengthening"of"pre/existing"synapses"or"synaptogenesis."
Some" of" them" are" calcium/calmodulin/dependent" kinase" II" (CaMKII)," cAMP/dependent"
protein"kinase"A"(PKA),"cGMP/dependent"protein"kinase"(PKG),"phosphoinositide/3"kinase"
(PI3K)," cyclin/dependent" kinase" 5" (CdK5)," protein" kinase" C" (PKC)" and" brain" atypical" PKC"
(PKMζ),"Fyn"tyrosine"kinase,"casein"kinase"2" (CK2)"and"p21/activated"kinase" (PAK)" (Giese"
and"Mizuno,"2013).!
PI3K"in"particular,"phosphorylates"phosphatidylinositols"that"subsequently"activate"PDK"(3/
phosphoinositide/dependent"kinase)"and"Akt,"both"downstream"elements"of"the"canonical"
PI3K/Akt"pathway."PI3K"activation"is"regulated"by"tyrosine"kinase"receptors"like"the"BDNF"
receptor" trkB." This" activation" is" critical" for" long/term" memory" (LTM)" formation" as" the"
impairment"of"PI3K/Akt"signaling" in"trkB"mutants"suppress"LTM"(Musumeci"et"al.,"2009)."
mTOR"(mammalian"target"for"rapamycin)"and"GSK3/β,"downstream"effectors"of"PI3K/Akt"
pathway,"have"also" important" functions" in" LTM"and"memory"consolidation"and" retrieval"
(Bekinschtein"et"al.,"2007,"Hooper"et"al.,"2008,"Hong"et"al.,"2012,"Huang"et"al.,"2013).!
Furthermore,"PTEN" inhibition" in"hippocampal"and"cortical" regions"of"mice" showed"over/
activation" of" Akt" signaling," causing" macrocephaly," severe" dendritic" dystrophy" and"
dramatic"increase"in"spine"density"(Kwon"et"al.,"2006).!
Previous"data"from"our"lab"have"shown"that"PI3K"and"Akt"activation"elicit"the"increase"of"
synapse"number" in" larval"NMJs" and" adult" brain" interneurons" and"projection"neurons" of"
Drosophila* melanogaster" (Martin/Pena" et" al.," 2006," Acebes" et" al.," 2011," Acebes" et" al.,"
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2012)." In" the" same" line," inhibitors" of" the" PI3K/Akt" pathway" like" GSK3/β" reduced" the"
number"of"synapses"in"both"types"of"neurons."The"results"proved"the"synaptogenic"actions"
of"PI3K"and"Akt"in"an"age/independent"manner,"as"their"activation"at"different"times"in"the"
fruitfly"life,"generated"new,"supernumerary"and"fully"functional"synapses."The"genetically"
driven"increase"in"synapse"number"correlates"with"up/regulation"of"postsynaptic"densities"
(PSDs)" and" glutamate" receptors" (Jordan/Alvarez" et" al.," 2012)." Other" elements" of" the"
canonical"PI3K/Akt"pathway" like"PTEN,"FoxO"and"mTOR,"had"no"effect" in" the"number"of"
synapses," suggesting" that" a" specific" pathway" for" synapse" number" regulation" was" being"
characterized," in"which" PI3K," Akt" and"GSK3/β" played" central" roles."Other" studies" report"
that"the"transcription"factor"AP1,"Jun"Kinase"and"Wnt"signaling,"also"modulated"by"GSK3/β,"
are" implicated" in"this"synaptogenic"pathway"(Franciscovich"et"al.,"2008)."Moreover,"BMP"
(bone"morphogenetic"protein)"canonical"signaling,"transcriptional"regulator"Mad"(SMAD1)"
and" Type" II" BMP" receptor" Wit" (wishfull" thinking)" are" key" regulators" of" synaptic"
development"and"maturation"in"the"Drosophila"NMJ"(Berke"et"al.,"2013)."
Using" the"Drosophila" larval"NMJ," data" from"our" lab" have" shown" that" PI3K/synaptogenic"
actions" are" part" of" a" larger" signaling" pathway," connected" with" other" previously" known"
elements" including:" the" Wit" receptor," its" ligand" Gbb" (glass" bottom" boat)," and" the"
MAPkinases"cascade." In"addition,"an"antagonistic"pathway"uses" the" transcription" factors"
Mad" and"Medea," the" co/factor" Yorkie" and" the"microRNA" bantam" to" down/regulate" key"
elements" of" the" pro/synaptogenic" pathway." Like" its" counterpart," this" anti/synaptogenic"
pathway"also"makes"use"of"a"small"GTPase"and"MAPKs"signals"including"Ras/like/a,"p38"and"
Licorne." Thus," the" number" of" synapses" results" from" the" balanced" output" from" the" two"
signaling"pathways.""
Interestingly," the" PI3K/Akt" signaling" pathway" is" well/conserved" across" species" (Ruggero"
and" Sonenberg," 2005)" and" PI3K" synaptogenic" actions" have" recently" been" tested" in"
mammals"with"PTD4/PI3KAc"administration"(chapter"3"for"details),"resulting"in"conserved"
functions"producing"up/regulation"of"synaptic"spines"in"mice"primary"hippocampal"neuron"
cultures" (Cuesto" et" al.," 2011)" and" in" vivo" cognitive" and" learning" abilities" enhancement"
(Enriquez/Barreto"et"al.,"2014).!
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Cytoskeletal"associated"proteins" like"kinesin/1"and"dynein"are"cargo"elements" that"allow"
transportation" of" synaptic" components" necessary" for" synapse" formation," maintenance,"
growth" and" function." Disruption" of" intracellular" transport" has" resulted" in" synaptic"
morphological" abnormalities" and" BMP" signaling" perturbations" (Kang" et" al.," 2014)."
Similarly,"direct" regulators"of"cytoskeleton"dynamics"have" important"effects" in"synapses."
For" instance," GSK3/β" can" regulate" microtubule" dynamics" by" stabilizing" Futsh;" Wingless"
(Wg)"regulates"planar"cell"polarity"(PCP)"by"activation"of"Dvl"(Dishevelled)"and"c/Jun"kinase"
(JNK)"that"directly"controls"microtubule"stability."BMP"can"also"regulate"the"cytoskeleton"
by" inducing"Wit" activation," Mad" (Mothers" Against" Decapentaplegic)" and" Med" (Medea)"
translocation"to"the"nucleus,"where"the"complex"Mad/Med"regulates"transcription"of"the"
RhoGEF"Trio"that"controls"actin"remodeling"(Long"and"Van"Vactor,"2013)."
!
3.!AIM!OF!THIS!THESIS!
Our"group"has"previously"demonstrated" that"elements"of" the"PI3K/AKT"pathway"control"
synapse" number" in" addition" to" their" well/known" roles" on" cell" survival" and" cell" growth,"
thus,"knowing"that"synapse"loss" is"one"of"the"first"steps"leading"to"neurodegeneration"in"
AD,"and" that" the"accumulation"of"β/amyloid"peptides" from"the"APP"has"been" related" to"
the" onset" of" the" pathology," the" aim" of" this" thesis" pose" the" question" of" whether" PI3K"
synaptogenic"actions"could"be"effective"against"the"synaptotoxic"effects"of"Aβ42,"both"in"
Drosophila* studies" and" in" a" human" neuroblastoma* in* vitro" system." The" potential"
synaptogenic"actions"of"PI3K"will"be"addressed"in"an"adult/onset"AD"model"in"Drosophila"
ausing" the"binary"Gal4/UAS"expression"system," together"with" the"Gal80ts" repressor."This"
strategy"will"allow"space"and"temporal"control"of"the"human"Aβ42"peptide"expression"in"
the" nervous" system." Furthermore" the" scope" will" include" the" search" for" novel" non/
synaptogenic" roles" of" PI3K" activation" in" Aβ42" induced" degeneration," in" neurons" and" in"
non/neuronal"tissues."
"
!
! !
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Box!1:!APP!
The"Amyloid"Precursor"Protein"(APP)"belongs"to"the"evolutionary"conserved"family"of"type"
I"transmembrane"glycoproteins"that"include"the"paralogs"amyloid"precursor/like"proteins"1"
and" 2" (APLP1" &" APLP2)," which" lack" the" Aβ" sequence" and" appear" to" show" redundant"
functions"(Goldgaber"et"al.,"1987,"Wasco"et"al.,"1993).!
The"extracellular"region"of"the"human"protein"contains"a"heparin/binding"domain"(HBD),"a"
cooper"binding"domain"(CuBD),"an"acidic"domain"(Ac),"a"Kutniz"protease"inhibitor"domain"
(KPI)" and" an" E2" domain." The" intracellular" region" contains" the" YENPTY" motif." The" Aβ"
sequence"is"in"the"transmembrane"region,"between"the"YENPTY"motif"and"the"E2"domain.!
Across" species,"Aβ" sequence" is"only" found" in" the"human,"Mus*musculus" and"Dario* rerio"
(Appa)"homologs."Together"with"APLP1"and"APLP2,"Caenorhabditis*elegans"and"Drosophila*
melanogaster" homologs" lack" the" Aβ" sequence." The" absence" of" Aβ" conservation" across"
species" points" out" the" fact" that" amyloidosis" could" not" be" the" main" function" of" APP."
According"to"this,"it"has"been"extensively"documented"that"APP"has"fundamental"roles"in"
cell"functions"that"range"from"neurogenesis"to"morphogenesis,"along"with"synaptogenesis,"
synapse"maintenance,"neurite"growth"and"axonal"guidance.!
There"are"3"major"isoforms"of"human"APP,"which"are"generated"by"alternative"splicing"of"
exons"7"and"8:"APP770,"APP751"and"APP695."The"APP"gene"is"located"in"chromosome"21"and"
is" ubiquitously" expressed" since" early" stages" of" development," mainly" in" the" brain" and"
kidneys."APP695"is"the"most"abundant"isoform"in"neurons,"and"APP770"and"APP751"are"more"
abundant"in"glial"cells."
Previous"studies"have"demonstrated"that"Drosophila"APP"homolog"APPL"regulates"synapse"
formation" and" neuromuscular" junction" (NMJ)" appearance" (Torroja" et" al.," 1999a)." APPL"
overexpression" produces" axonal" transport" disruption" by" interacting" with" kinesin" heavy"
chain" (Torroja" et" al.," 1999b)," and" Appl" null" flies" show" decreased" number" of" synaptic"
boutons"in"larval"NMJs"(Torroja"et"al.,"1999a)."
More"recent"work"has"described"a"new"function"of"Drosophila"APPL"protein"as"modulator"
of"the"Wnt"Planar"Cell"Polarity"(PCP)"signaling"pathway"in"axonal"outgrowth"by"modulation"
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of" the" receptor" Dishevelled" (Dsh)" by" Abelson" kinase" (Abl)" mediated" phosphorylation"
(Soldano"et"al.,"2013)."!
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Box!2:!PI3K!
PI3K"or"phosphoinositide/3"kinase" is"an" intracellular"family"of"proteins"that" includes"four"
different" classes:"Class" I" are"heterodimers"of"a" catalytic" subunit" (p110)"and"a" regulatory"
subunit" (p85)," responsible" for" the"production"of"PI(3)P,"PI(3,4)P2"and"PI(3,4,5)P3."Class" II"
members" have" three" catalytic" subunits" and" no" regulatory" subunits." Class" III" are"
heterodimers" composed" of" a" catalytic" subunit" (Vps34)" and" a" regulatory" subunit"
(Vps15/p150)" that" are" involved" in" vesicles" and" protein" trafficking." Finally," Class" IV" are"
serine/threonine" kinases" like" mTOR," DNA/dependent" protein" kinase" (DNA/PK)," among"
others.!
PI3K"constitutes"a"cell/signaling"crossroad,"as"it"is"implicated"in"proliferation,"survival,"cell"
growth,"motility," differentiation," and" intracellular" transport" (Grundke/Iqbal" et" al.," 1986,"
Engelman"et"al.,"2006,"Acebes"and"Morales,"2012,"Knafo"and"Esteban,"2012,"Menon"et"al.,"
2014)."The"canonical"activation"of"PI3K"is"mediated"by"RTKs"(Receptors"of"tyrosine"kinases)"
phosphorylation" and" the" subsequent" recruitment" and" conformational" change" of" PI3K"
heterodimers."These"events"allow"the"phosphorylation"of"the"catalytic"subunit"triggering"
PIP2" transformation" to" PIP3," which" mediates" Akt" phosphorylation" that" later" activates"
multiple"downstream"effectors"as"mTOR,"CREB,"FOXO…"etc."Activators"of"the"pathway"are"
Insulin,"EGF,"IGF/1"and"shh."Inhibitors"of"the"pathway"are"GSK3/β"and"PTEN.!
In"Drosophila,*there"are"3"genes"encoding"PI3K."In"particular,"PI3K/92E"encodes"one"PI3K"
isoform" with" a" catalytic" subunit" (Dp110)" and" a" regulatory" subunit" (Dp60)" that" present"
strong"homology"with"of"human"class"I"PI3K"p110"and"p85"subunits"respectively."!
! !
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Box!3:!Drosophila!Adult!NMJ!
Larval"neuromuscular"junction"(NMJ)"has"been"utilized"because"of"its"easy"accessibility,"in"
numerous" studies" during" decades" to" address" synaptic" plasticity" mechanisms" and"
development" (Keshishian" et" al.," 1996)." However," to" evaluate" neurodegeneration" and" to"
distinguish" from" developmental" defects," the" adult" NMJ" is" a"more" suitable" tissue." Adult"
ventral" longitudinal" muscle" (VLM)" NMJs" have" been" characterized" (Hebbar" et" al.," 2006,"
Wagner"et"al.,"2015).!
VLM"NMJs" have" one" single" nerve" entry" point" innervating" the"muscle" and" present" large"
glutamatergic"boutons" (Hebbar"et" al.," 2006)."VLM"NMJs" synapses" consist"of"presynaptic"
active"zones"(AZs)"and"associated"postsynaptic"membranes"(Wagner"et"al.,"2015)."AZs"are"
specialized" membrane" compartments" at" the" axonal" terminal" where" neurotransmitter"
release"occurs," and"present" a" T/bar" electro"dense" structure"when" imaged"with" electron"
microscopy."!
AZs"are"composed"of"evolutionarily"conserved"proteins" like:"ELKS/CAST/BRP"(bruchpilot),"
Piccolo,"Bassoon,"CASK,"Mint,"RIM,"Liprin/α"and"Syd/1;"docking"proteins"such"us"Munc/13,"
Munc/18," SNAREs," SNAP25," Synaptobrevin/VAMP" and" syntaxin;" cell" adhesion"molecules"
like"SYG/1/Neph1,"SYG/2/Nephrin,"Neurexin"and"Neuroligin;"actin"and"tubulin"cytoskeletal"
components" like" actin," tubulin," myosin," spectrin," β/catenin" and" WVE/1/WAVE" complex"
(Sudhof,"2012).!
In"vertebrates,"NMJs"contain"elongated"AZs"to"which"neurotransmitter"containing"vesicles"
attach." Invertebrate" NMJs" are" similar" to" central" vertebrate" synapses," although" they"
present" the"T/bar" shape," similar" to" the" synaptic" ribbon" structures"of" sensory" vertebrate"
neurons"(Sudhof,"2012).!!
! !
! 19"
Box!4:!Drosophila*melanogaster!AD!Models!
Many"model"organisms" such"as"Drosophila*melanogaster,"Caenorhabditis* elegans,"Dario*
rerio" (zebrafish)" and"Mus*musculus" (mouse)" serve" to"model" Alzheimer’s" disease" (Hirth,"
2010,"Wisniewski"and"Sigurdsson,"2010,"Rincon/Limas"et"al.,"2012,"De"Felice"and"Munoz,"
2016).!
Drosophila* in"particular"offers"advantages"over"the"other"systems"due"to"the"shorter" life"
cycle," lower" cost," smaller" body" size" and"more" importantly" a"wide" spectrum"of" available"
genetic" tools" that" allow" faster" genetic" screens;"moreover"Drosophila" can" be" use" to" test"
candidate"therapies"and"drugs"(Rincon/Limas"et"al.,"2012,"Ugur"et"al.,"2016).!
Fly" models" of" AD" have" been" generated" following" different" strategies." Some" studies"
coexpress" human" APP" and" human" BACE" (β/secretase)," and" describe" consequent" Aβ"
plaques" formation" and" age/dependent" neurodegeneration" (Greeve" et" al.," 2004)" with"
decreased" presynaptic" connections," altered" mitochondrial" localization" and" reduced"
postsynaptic"protein"levels"(Mhatre"et"al.,"2014).!
Other"models" are" based"on" the"human"β/amyloid" peptide" expression." For" this" strategy,"
different" Aβ" constructs" have" been" developped," the" UAS/Aβ40" (Iijima" et" al.," 2004)," that"
produces"no"plaque"formation"but"causes"age/dependent" learning"defects;"the"UAS/Aβ42"
that"elicits"synaptic"alterations"and"locomotor,"survival"and"learning"impairments"(Iijima"et"
al.,"2008)"and"other"Aβ"constructs"that"present"AD"associated"mutations"like"the"UAS/Aβ42/
Arc"and"are"more"aggregation"prone"models"(Crowther"et"al.,"2005,"Iijima"et"al.,"2008).""
Recently," the"construct"2x/UAS/Aβ42,"has"been"generated"and"characterized" (Casas/Tinto"
et" al.," 2011)," consisting" in" a" bi/cistronic" system" (2" tandem" copies)" of" the" human" Aβ42"
fused"to"a"secretion"signal."This"model"shows"extensive"neuronal"cell"death"and" induces"
XBP1" unconventional" splicing." The" 2x/UAS/Aβ42" genetic" construct," allows" stronger"
neurotoxic" phenotypes" that" develop" faster" than" in" other" 1/copy"models," facilitating" the"
search"for"suppressor"candidates.!
All" these" studies" have" shed" light" on" the" molecular" mechanisms" underlying" Aβ"
neurotoxicity,"and"moreover,"to"the"possible"targets"and"therapies"that"could"be"used"to"
prevent"its"deleterious"effects."Many"researchers"have"described"GSK3/β"activation"upon"
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Aβ" expression," which" can" produce" APP" transport" alterations" by" affecting" kinesin/1" and"
dynein"(Weaver"et"al.,"2013)."Others"have"shown"that"GSK3/β"inhibition"can"restore"some"
of"the"Aβ"toxic"effects,"as"well"as"lithium"or"Congo/Red"treatment"(Crowther"et"al.,"2004,"
Sofola" et" al.," 2010," Sofola/Adesakin" et" al.," 2014)." However," other" authors" found" no"
restoration"when"they"down/expressed"shaggy"(the"Drosophila"homolog"of"GSK3/β)"in"Aβ"
expressing" neurons," claiming" no" Wnt/Aβ" interaction" in" Drosophila" AD" models"
(Luchtenborg"and"Katanaev,"2014)."PI3K"inhibition"by"down/expression"of"p65"regulatory"
subunit" has" also" been" used" in" Aβ" Drosophila," showing" prevention" of" Aβ/induced" LTD"
(Chiang"et"al.,"2010)."
" "
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SCOPE"
!
!
The"objectives"of"this"thesis"are"the"following:"
"
1. To"study"the"synaptogenic"actions"of"PI3K"in"AZs"in"an"adult/onset"AD"model"
2. To"analyze,"from"a"whole"organismal"level,"the"potential"beneficial"effects"of"PI3K"
overexpression"in"Aβ42"neurodegeneration"
3. To" study" of" the" synaptogenic" actions" of" Medea" down/regulation" and" mTOR"
overexpression"in"Aβ42/mediated"neurodegeneration"
4. To"characterize"a"novel"effect"of"PI3K"activation"in"Aβ42"aggregation"
5. To" identify" novel" Aβ42" phenotypes" in" non/neuronal" environments" and" evaluate"
the"potential"actions"of"PI3K"in"these"contexts"
" "
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MATERIALS"AND"METHODS"
!
!
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MATERIALS"
!
Drosophila!genetics,!stocks!and!maintenance!
All"fly"stocks"were"maintained"at"25°C"(unless"otherwise"specified)"on"a"12/12/h"light/dark"
cycle"at"constant"humidity" in"standard"medium"(4%"glucose,"55g/l"yeast,"0,65%"agar,"28"
g/l"wheat"flour"and"4"ml/l"propionic"acid)."
"
Gal4/UAS*system*
For"ectopic"expression"of"genes,"the"Gal4/UAS"binary"system"was"used"(Brand"&"Perrimon,"
1993),"in"which"the"yeast"transcriptional"activator"Gal4"is"used"to"allow"the"expression"of"a"
gene" of" interest" (gene" X)" under" the" regulation" of" UAS" sequences" (Upstream"Activating"
Sequence)."
To"report"the"activity"of"specific"enhancers"we"have"used"‘enhancer/trap"Gal4"lines’."These"
transgenic" lines" carry" a" P" element" including" the" cDNA" of" Gal4" transcriptional" activator."
This"P/element"is"randomly"mobilized"through"the"genome"and,"as"a"consequence,"specific"
insertions"drive"the"expression"of"the"Gal4"under"the"control"of"nearby"endogenous"tissue/
specific"enhancers."When"Gal4"lines"are"crossed"by"UAS"lines,"the"gene"of"interest,"cloned"
downstream"of"UAS"sequences,"is"expressed"in"the"same"pattern"as"the"Gal4"activator."It"is"
important"to"note"that"this"gene"will"not"be"transcribed"in"the"absence"of"the"Gal4"protein."
!
*
Gal80ts*system*
The"Gal4/UAS"system"presents"one"important"limitation,"as"it"is"not"possible"to"induce"its"
activation"at"specific"times"in"the"life"cycle"of"the"organism."To"address"this"issue,"another"
yeast"protein,"the"Gal80,"is"used"to"specifically"bind"and"repress"Gal4"function."
By"using"a"temperature/sensitive"allele"of"Gal80"repressor"under"the"control"of"the"tubulin"
promoter" (tub8Gal80ts)," the" activation" and" repression" of" the" Gal4/UAS" system" can" be"
regulated" by" temperature." Gal80ts" protein" is" not" functional" at" 29°C," so" the" Gal4/UAS"
system" is" active" at" this" temperature." On" the" other" hand," Gal80ts" is" functional" at" 17°C,"
repressing"the"Gal4/UAS"(McGuire"et"al.,"2003)."
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This" construct" is" highly" instrumental" in" situations"where" the" gene" of" interest" is" causing"
toxic" or" lethal" effects" that" restrict" the" study" to" early" stages" of" development." In" these"
situations,"Gal80ts"can"be"used"to"activate"the"expression"of" the"gene"of" interest"only"at"
later" stages"of"development."This"was" the"case" in" the"study"of" the" toxic"effects"of"Aβ42"
during"development."
Additionally," several" GAL4" lines" show" dynamic" expression," with" patterns" changing"
throughout"development"and"adulthood"(Chapter"8)."The"use"of"Gal80ts"construct"can"also"
prevent"this"event."
!
Flip8Out*Clones*&*G8TRACE*system*
Flip/out"clones"consist"in"the"excision"of"a"given"DNA"sequence"by"Flipase"induced"mitotic"
recombination"between"FRT"sites"(Flipase"Recognition"Target),"situated"flanking"the"gene"
of"interest"(Struhl"&"Basler,"1993)."
The" Gal4" technique" for" real/time" and" clonal" expression," or" G/TRACE" analysis" system,"
consists" on" a" UAS/RFP" fluorescent" protein" construct;" a" UAS/Flipase" and" a" tracking"
construct"Act/FRT/STOP/FRT/GFP"that"reports"the"temporal"activation"of"an"enhancer"over"
time."The"Gal4"activity"induces"the"expression"of"the"UAS/Flipase"(Flp)"and"UAS/RFP"(red)"
constructs."The"Flp"enzyme"recognizes"FRT"sites"and"removes"the"STOP"cassette,"allowing"
the" expression"of"Act>GFP" (green)" in" these" cells" and," thus," expressing" the"GFP" reporter"
independently"from"the"enhancer"that"controlled"the"Gal4"driver"under"study."In"this"way,"
we" can" determine" the" current" expression" of" an" enhancer/Gal4" in" the" moment" of"
dissection"(red,"RFP)"and"the"historical"expression"during"development"(Act>GFP"(green))."
Using"this"system,"it"has"been"described"that"some"enhancer/Gal4" lines"show"divergence"
of"their"expression"domains"at"different"stages"of"development"(Evans"et"al.,"2003)."
"
The"following"stocks"were"used"in"this"work:"
"
GAL4!lines""
Stock!Name! Bloomington!Reference/Source! Reference!
elavc155/Gal4"(Chr."X)! BL/458! Lin*et*al.,*1994!
D42/Gal4! BL/8816! Chan*et*al.,*2002!
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Stock!Name* Bloomington!Reference/Source" Reference*
leucokininM7/Gal4! F."Benjumea"(CBMSO)" de*Haro*et*al.,*2010!
engrailed/Gal4! BL/1973 " Lawrence*et*al.,*1995!
rotund/Gal4! BL/7405" St.*Pierre*et*al.,*2002!
elav/Gal4"(Chr."II)! BL/8765! Luo*et*al.,*1994!
elav/Gal4"(Chr."III)* BL/8760! Luo*et*al.,*1994!
Tubulin/Gal80ts" BL/7019"" McGuire*et*al.,*2003*
*
elav/Gal4;Gal80ts" was" generated" in" the" lab" for" this"work"with" elavc155/Gal4" (Chr." X)" and"
Tubulin/Gal80ts".!
!
UAS!lines:!
Stock!Name!
Bloomington!
Reference/Source! Reference!
UAS/LacZ*" BL/1776" (Brand"and"Perrimon,"1993)"
UAS/PI3K! BL/8294" (Parrish"et"al.,"2009)"
UAS/mTOR! BL/7013" (Hennig"and"Neufeld,"2002)"
UAS/bsk! BL/9310" (Boutros"et"al.,"1998)"
UAS/MedeaRNAi* BL/31028"" (Ni"et"al.,"2009)"
UAS/Aβ42(2x)" Dr."Pedro"Fernández"Fúnez" (Casas/Tinto"et"al.,"2011)"
UAS/EB18GFP" Dr."Melisa"Rolls" (Rolls"et"al.,"2007)"
"
UAS/Aβ42(2x)/UAS/GFPnLs,!UAS/PI3K/UAS/Aβ42(2x),!UAS/mTOR/UAS/Aβ42(2x)"and**UAS/
MedeaRNAi/UAS/Aβ42(2x)"lines"were"generated"in"the"lab"for"this"work."
Other!lines;!G/TRACE"(BL/28280)!
!
List!of!Primary!and!Secondary!Antibodies!!
!
Antibody! Tech.! Protein! Species! Dilution! Source!
nc82" IHC" Bruchpilot" mouse" 1:20" DSHB"
hrp" IHC" Horseradish"peroxidase" rabbit" 1:200" DSHB"
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Antibody" Tech." Protein" Species" Dilution" Source"
6E10"
"
IHC" Amyloid"Beta"
"
mouse" 1:1500" Covance"
WB" 1:1000"
csp/3" IHC" Activated"caspase/3" rabbit" 1:100" Cell"
Signaling"
wg" IHC" Wingless" mouse" 1:20" DSHB"
pH3" IHC" phospho"Histone/3" rabbit" " Millipore"
arm" IHC" armadillo" mouse" 1:50" "
elav" IHC" Elav" mouse" 1:50" DSHB"
pSer" IHC" phospho/Serine" mouse" 1:200" Abcam"
pTyr" IHC" phospho/Tyrosine" rabbit" 1:200" Abcam"
pSer8/Aβ" IHC" phospho/Serine8/Aβ42" mouse" 1:1000" Jochen"Lab"
pSer26/Aβ" IHC" phospho/Serine26/Aβ42" rat" 1:1000" Jochen"Lab"
β/Tub" WB" β/Tubulin" mouse" 1:10000" Abcam"
" " " " " "
Secondary!Antibodies!
Alexa"488" IHC" Alexa"Fluor"488"dye" mouse" 1:300" TFS"
Alexa"568" IHC" Alexa"Fluor"568"dye" rabbit" 1:300" TFS"
Alexa"647" IHC" Alexa"Fluor"647"dye" rat" 1:300" TFS"
"
"
Cell!Culture"
SH/SY5Y" human" neuroblastoma" cells" were" purchased" from" ATCC" (ref:" CRL/2266)." Cells"
were" seeded" at" 5x104" cells/cm2" and"used"when" cultures" reached" a" 70–80%" confluence."
Culture" media" contained" RPMI" (Sigma/Aldrich," USA)" supplemented" with" 0.5" mM"
glutamine"(Sigma/Aldrich,"USA),"penicillin"(50"mg/ml)/streptomycin"(50"U/ml)"from"Sigma/
Aldrich" (USA)," and" 10%" FBS" (Sigma/Aldrich," USA)." Cells" were" serum" starved" and"
differentiated"with"retinoic"acid"(10"μM)"for"24"hours"prior"to"treatment."
"
"
"
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PI3K!Activating!Peptides!
Activation"of"PI3K"was"achieved"by"using" the"peptide"PTD4/PI3KAc" (Cuesto"et"al.,"2011)."
The" peptide" includes" a" PTD$/transduction" domain" that" allows" membrane"
permeabilization," PTD4" (Tyr/Ala/Arg/Ala/Ala/Ala/" Arg/Gln/Ala/Arg/Ala)," (Ho" et" al.," 2001),"
fused"to"a"phosphopeptide"containing"the"intracellular"phosphorylated"SH2"domain"of"the"
PDGF" receptor" (Gly/Ser/Asp/Gly/Gly/pTyr/Met/Asp/Met/Ser)," (Derossi" et" al.," 1998)." This"
peptide"has"been"shown"to"induce"class"I"PI3K"activation,"independently"of"tyrosine"kinase"
dimerization," both" in* vitro" and" in* vivo*brains" (Cuesto" et" al.," 2011)." Peptides"were" a" gift"
from"Dr."Miguel"Morales"Lab."
!
! !
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METHODS"
!
Preparation!of!Aβ42!Oligomers!
Soluble"oligomers"were"prepared"by"dissolving"0.3"mg"Aβ42,"previously" re/solubilized" in"
formic"acid," in"200"μl"of"hexafluoroisopropanol" (HFIP)" for"20"min."at" room"temperature."
200" μl" of" this" Aβ42" solution"were" added" to" 1ml"Milli/Q" H2O" in" a" siliconized" eppendorf"
tube."The"samples"were"then"stirred"at"500"rpm"using"a"Teflon"coated"micro"stir"bar"for"8h"
at"22°C"for"evaporation"of"the"HFIP"and"progressive"formation"of"oligomers."Before"using"
Aβ42"oligomers"for"cytotoxicity"assays,"the"samples"were"sonicated"to"break"and"prevent"
incipient"fibers"(Kayed"and"Glabe,"2006)."
!
Protein!Extraction!and!Western!Blot!Analysis!
Ten" fly" heads" from"each" genotype"were" used" to" prepare" homogenates." Fly" heads"were"
homogenized" in" 20" μl" of" lysis" buffer" containing" PBS1x," Triton" 1%," 150" mM" NaCl" and"
Complete" Protease" Inhibitors" (Roche)." Equal" volume" of" Tricine/SDS" and" 5%" β/
mercaptoethanol" loading" buffer" was" added" to" each" sample." Later," the" samples" were"
boiled" at" 95°C" for" 5"min." Protein" extracts"were" fractionated"by" sodium"dodecyl" sulfate/
polyacrylamide" gel" electrophoresis" (SDS" –" PAGE)" in" 15%" Bis–Tris" under" reducing"
conditions"and"electroblotted" into"0,22"μm"nitrocellulose"membranes."Membranes"were"
then"blocked" in"PBS"containing"5%"non/fat"milk,"and"probed"against"Aβ42"(6E10)"and"β/
Tubulin."To"improve"reactivity"of"6E10"antibody,"membranes"were"boiled"for"5"min"in"PBS"
before"blocking."Immunoreactive"bands"were"visualized"by"enhanced"chemiluminescence"
(ECL,"Amersham)."Quantification"of"relative"expression"was"done"from"three"independent"
experiments"using"a"loading"control"for"normalization."The"signal"intensity"was"quantified"
using"ImageJ"(NIH)"software."
!
Insoluble*vs*Soluble*Protein*Separation*
Ten"fly"heads"were"hand"homogenized"in"40"μl"of"lysis"buffer"and"centrifuged"for"1"min."at"
1300"rpm."The"supernatant"was"stored"as"the"Soluble"Fraction."The"remaining"pellet"was"
resuspended" in" 30" μl" of" PBS" with" 1%" Triton" X/100" and" 30" μl" 70%" formic" acid." After"
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sonication," vortex" shaking" and" 800" rpm" centrifugation" for" 1"min.," the" supernatant" was"
dried"with"SpeedVac"for"1"hour."The"dried"pellet"was"finally"resuspended"in"40"μl"of"PBS"
with" 1%" Triton" X/100," sonicated" and" centrifuged" again" at" 1300" rpm." The" resulting"
supernatant"was"stored"and"named"Insoluble"Fraction."
"
Monomerization*Protocol"
20μl"of"Monomerization"Buffer"(9M"Urea,"1%"SDS,"25mM"Tris/HCl,"1mM"EDTA)"was"added"
to" total," insoluble" or" soluble" protein" fractions." The" samples" were" then" sonicated" and"
incubated" for" 1" hour" at" 55" °C," followed" by" centrifugation" at" 14000" rpm" for" 2"min." The"
supernatants"were"mixed"with"loading"buffer"and"boiled"at"95"°C"for"5"min."
!
RNA!Isolation!and!cDNA!Preparation!
Total" RNA" was" isolated" from" 15" fly" heads" per" genotype" (Trizol," Invitrogen)" and" cDNAs"
were"synthetized"using"M/MLV"Retrotranscriptase"(Invitrogen).!
! !
Quantitative!RT<!PCR!
qPCR" analysis" was" done" using" 7500" Real" Time" PCR" System" (Applied" Biosystems)" with"
cycling"conditions"of"95°C" for"10"min"and"40"cycles"of"95°C" for"15"s"and"55°C" for"1"min."
qPCR"results"were"analyzed"with"7500"v2.0.6"software"(Applied"Biosystems)."
!
Immunostaining!
Third"instar"larval"tissues"and"adult"brains"were"dissected"and"fixed"with"4%"formaldehyde"
in" phosphate/buffered" saline" for" 20" minutes," washed" 3" times" with" 0,1%" triton," and"
mounted" in" Vectashield" mounting" medium" with" DAPI," or" incubated" with" primary" and"
secondary"antibodies."(Tables"in"chapter"3"/"Materials)"
Preparations"were"imaged"in"a"Leica"SP5"confocal"microscope.""
!
Thioflavin!S!Histochemistry!
7/day" old" and" 15/day" old" female" fly" brains" were" fixed" in" 4%" formaldehyde" and"
permeabilized" in" PBS" containing" 0.4%" Triton" X/100." The" brains" were" incubated" in" 50%"
EtOH"containing"0.1%"TS"(Sigma)"for"10"min."and"later"washed"in"50%"EtOH"and"PBS."
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"
Larval!Wing!Disc!Live!Imaging!
First"and"second"instar" larval"wing"imaginal"discs"were"visualized"and"imaged"following"a"
previously"published"protocol"(Nienhaus"et"al.,"2012)."Preparations"were"imaged"in"a"Leica"
SP5"confocal"microscope."!
!
EB1<GFP!Live!Imaging!
Third"instar"larvae"were"washed"in"PBS,"dried"and"placed"in"a"drop"of"halocarbon"oil"700"
and"10%"chloroform"mixture."Dendritic"arborization"dorsal"cluster"sensory"neurons"(ddA)"
live" imaging" was" performed" in" the" dorsal" side" of" the" extended" larva" with" a" 60x" oil"
immersion"objective"in"a"spinning"disk"microscope."
Laser"intensity"was"maintained"to"15%"in"all"experiments."The"time/lapse"acquisition"was"
done"for"a"total"time"of"3"min."with"2"sec."interval"time."
!
Negative!Geotaxis!Assays!
A"total"number"of"30"to"48"female"flies"per"genotype"were"grown"at"29°C"since"eclosion,"
allowing" the" Gal4/UAS" system" to" activate" the" expression" of" the" corresponding" genes"
thanks"to"the"inactivation"of"the"Gal80ts"repressor."Females"were"separated"and"placed"in"
plastic" vials" containing" ten" to" fifteen"of" them,"and"kept" at" 29°C," 70%"humidity," under" a"
12/12/h" light/dark" cycle." The" counting"was"done"at" 25°C"every"2/3"days" in" a"plastic" vial"
that"was"gently"tapped"to"the"bottom."The"number"of"flies"that"reached"the"4"cm."high"line"
was"counted"after"10"sec."of"climbing;"at"the"same"time,"the"number"of"flies"that"started"
climbing" but" did" not" reached" the" 4cm" line," and" the" number" of" flies" that" stayed" at" the"
bottom" of" the" tube," were" also" annotated." Every" counting" was" repeated" 8" times." The"
experiment"was"repeated"at"least"three"times."
!
Lifespan!Analysis!
A"total"number"of"30"to"48"female"flies"per"genotype"were"grown"at"29°C"since"eclosion,"
allowing"the"Gal4/UAS"system"to"activate"the"expression"of"the"corresponding"genes."Flies"
were"separated"in"groups"of"ten"to"fifteen"females,"and"placed"in"food"vials."Each"vial"was"
kept" at" 29°C," 70%"humidity," under" a" 12/12/h" light/dark" cycle." Food" vials"were" changed"
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every"2/3"days,"and"the"dead" flies"were"counted"at" that" time."Experiments"were"carried"
out"in"triplicates."
Statistical"analysis"was"performed"using"Mantel/Cox"test"with"GraphPad"software.!
!
Image!Analysis!
Fluorescence"quantification"was"performed"with"Imaris"(Bitplane)"software." Images"were"
processed"with"ImageJ.!
!
Adult!NMJ!Synapse!Analysis!
Adult"female"flies"of"7,"15"and"25"(±"0/3)"days"of"age"were"dissected"under"the"microscope."
In" order" to" isolate" the" abdominal" muscles" and" its" corresponding" innervating" motor"
neurons."Briefly,"adult" flies"were"anesthetized"with"CO2"and" immobilized"with"dissection"
pins" in"Silgar"polymere"plates"with"their"dorsal"side"up."Flies"when"then"submerged" in"a"
drop"PBS/1X"containing"formaldehyde"(4%),"allowing"the"fixing"process"to"start."A"dorso/
longitudinal"cut"was"done"along"the"abdomen"and"dissection"pins"were"used"to"open"the"
abdomen"in"a"wide/open/book"manner."Fat"and"non/required"tissues"were"removed."After"
a"total"fixation"process"of"20"minutes,"the"abdomens"were"washed"with"PBS/1X"containing"
0,1%"triton"and"transferred"to"4/well"plates"for"immunostaining."
Synapses" were" revealed" by" the" primary" mouse" monoclonal" antibody" nc82," which"
recognizes"the"CAST"homolog"bruchpilot"protein,"a"constituent"of" the"active"zone"of" the"
synapse." " Anti/HRP" rabbit" antibody" was" used" to" label" and" identify" the" motor" neuron"
membrane."
Finally,"the"samples"were"mounted"in"Vetashield"medium"after"incubation"with"secondary"
antibodies"anti/mouse"Alexa"488"and"anti/rabbit"Alexa"568."
To" quantify" the" active" zone" area," total" nc82" positive" signal" was" measured" in" the" third"
segment" VLM/NMJs" (adult" ventral" longitudinal" muscle" neuro" muscular" junctions)" with"
Imaris"(Bitplane)"software."This"estimation"procedure"was"required"as"some"of"the"mutant"
conditions" render"a"diffuse"nc82" signal"over" the"motor"neuron"membrane"as"oppose" to"
the"regular"individual"spots"appearance"(see"text)."""
"
!
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HT<SY5Y!Viability!Assay!
SH/SY5Y" human" neuroblastoma" cells" were" seeded" in" a" 96/well" plate" when" cultures"
reached" a" 70–80%" confluence," and" incubated" overnight" with" RPMI" culture" media"
supplemented"with" 10%" FBS" (see"Materials" for"more" details)." Cells" were" differentiated"
with" retinoic" acid" (10μM)" and"RPMI" containing" 2%" FBS." 24h" later," PTD4/PI3KAc"peptide"
was" added" to" the" wells" for" pre/treatment" studies." Aβ42" oligomers" were" added" to" the"
media"24h"after"the"first"treatment"of"PTD4/PI3KAc."For"co/treatment"experiments,"PTD4/
PI3KAc"peptide"was"added"at"the"same"time"as"Aβ42"oligomers."Finally,"for"Post/treatment"
studies," PTD4/PI3KAc" peptide" was" added" to" the" media" 24h" after" oligomer" addition."
Concentration" of" PTD4/PI3KAc" peptide" was" 50μg/ml" in" all" the" cases." Concentration" of"
Aβ42"oligomers"was"18μg/ml,"36μg/ml"or"72μg/ml."
"
"
HT<SY5Y!Aβ42!Aggregation!Assay!
SH/SY5Y"human"neuroblastoma"cells"were"seeded"in"a"12/well"plate"with"coverslips"when"
cultures"reached"a"70–80%"confluence,"and"incubated"overnight"with"RPMI"culture"media"
supplemented"with" 10%" FBS" (see"Materials" for"more" details)." Cells" were" differentiated"
with"retinoic"acid"(10μM)"and"RPMI"containing"2%"FBS"for"48"hours"prior"to"the"addition"of"
any" stimuli." Aβ42" oligomers" (36μg/ml)" and" PTD4/PI3KAc" (50μg/ml)" were" added" to" the"
media." Cells" were" incubated" with" the" stimuli" for" another" 48h" period" and" then" the"
coverslip"followed"the"standard"immunostaining"protocol"(described"above)."
The"6E10"positive"signal"was"analyzed"in"the"total"surface"of"the"coverslip"and"quantified"
with"Imaris"software.""
!
Aβ42!Extracellular!Aggregation!Assay!
Cells"were"seeded"and"differentiated"as"previously"described"in"HT8SY5Y*Aβ42*Aggregation*
Assay*(above)."In"this"case,"4"different"approaches"were"designed:""
1. Cells" supernatant" was" transferred" to" a" new" well," with" a" coverslip," after" 48h" of"
differentiation."Aβ42"oligomers"were"added"to"the"supernatant"and"incubated"for"
48h" before" immunstaining." This" experiment" was" an" internal" control" for" Aβ42"
aggregation."
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2. Differentiated" cells" were" treated" with" PTD4/PI3KAc" and" incubated" for" 48h," the"
supernatant" was" then" transferred" to" a" new" well," with" a" coverslip," were" Aβ42"
oligomers" were" added" and" incubated" for" another" 48h" prior" to" immunostaining."
This"experiment"was"named"PI3K"pre/treatment."
3. The" Supernatant" of" differentiated" cells" was" transferred" to" a" new" well," with" a"
coverslip,"after"48h"of"differentiation."In"the"new"well,"the"supernatant"was"treated"
with" PTD4/PI3KAc" and"Aβ42" oligomers" at" the" same" time," and" incubated" for" 48h"
before"immunostaining."This"experiment"was"named"PI3K"co/treatment."
4. Differentiated"cells"were"treated"with"Aβ42"oligomers"for"48h"prior"to"transfer"the"
supernatant" to" a" new" well," with" a" coverslip." The" supernatant" was" then" treated"
with" PTD4/PI3KAc" and" incubated" for" another" 48h" before" immunostaining." This"
experiment"was"named"PI3K"post/treatment."
The" 6E10"positive" dots" in" the" total" surface" of" the" coverslip"were" analyzed" and" counted"
with"Imaris"software.""
"
Statistical!Analysis!
All"data"are"shown"as"mean"±"standard"deviation"of"the"mean."
Statistical" significance" was" calculated" using" a" unpaired" Student's" two/tailed" t/test," with"
significant" differences" between" compared" groups" noted" by" *P≤0.05," **P≤0.01," and"
***P≤0.001."
"
" "
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CHAPTER!4!! ! STUDY!OF!THE!SYNAPTOGENIC!ACTIONS!OF!PI3K!IN!AZs!IN!AN!!
! ! ! ADULT<ONSET!AD!MODEL!
!
Previous" studies" have" demonstrated" the" synaptogenic" functions" of" PI3K" in" invertebrate"
and"mammal"neurons"(Martin/Pena"et"al.,"2006,"Acebes"et"al.,"2011,"Cuesto"et"al.,"2011)."
These" new" synapses" were" functional" and" supernumerary," as" quantified" in" larval" NMJ"
active"zones"(Martin/Peña"et"al,"2006;"Jordan/Alvarez"et"al,"2012),"and"adult"antennal"lobe"
inhibitory" interneurons" in" Drosophila" (Acebes" et" al.," 2011)," and" in" CA1" hippocampal"
cultured" neurons" in" mice" (Cuesto" et" al.," 2011)." Thus," PI3K" overexpression" becomes" a"
synaptogenic" tool" than" could" be" used" in" pathological" situations" where" synapses" are"
affected.""
In" this" work" we" ask" if" the" synaptogenic" functions" of" PI3K" are" effective" in" a"
neurodegenerative" model" of" Alzheimer’s" disease" in" Drosophila" where" human" Aβ42"
peptide"is"overexpressed"and"induces"synapse"loss."
"
4.1!PI3K!prevents!Aβ42!induced!neurodegeneration!"
To"determine"if"PI3K"can"rescue"the"loss"of"synapses"induced"by"Aβ42,"we"overexpressed"a"
constitutively" active" form" of" PI3K" and" the" human" Aβ42" peptide" within" the" pan/neural"
pattern" of" the" elav/Gal4" driver." To" discard" an" effect" during" development," we" used" the"
temperature" sensitive"Gal80TS" construct" to" activate" the"expression"of" the"desired" genes"
only"in"adult"stages."As"detailed"in"Chapter"3"(Materials"&"Methods),"flies"were"grown"at"
17°C,"and"transferred"to"29°C"when"they"reached"adulthood"to"allow"the"expression"of"the"
Gal4."
To"estimate"the"number"of"synapses,"we"aged"adult"flies"for"7,"15"and"25"days"(±"0/3"days),"
and" dissected" adult" abdomens" to" later" visualize" the" third" segment" ventral" longitudinal"
muscle" (VLM)" NMJs." Synapses" were" revealed" by" the" monoclonal" antibody" nc82," which"
recognizes"a"CAST"homolog"localized"in"the"active"zones"(presynaptic"region)"of"the"motor"
neuron.""Anti/HRP"antibody"was"used"to"label"and"identify"the"motor"neuron"membrane."
38"
To"quantify"the"active"zone"area,"nc82"total"positive"signal"was"measured"in"third"segment"
ventral"longitudinal"muscle"(VLM)"NMJs."(Chapter"3"for"more"details)."
At" 7" days" (Fig.! R1"A/D,E)," all" genotypes" had" similar" numbers" of" synaptic" area," and" no"
significant"changes"were"found,"suggesting"that"neither"of"the"genotypes"(Aβ42,"PI3K,"or"
PI3K/Aβ42)" had" altered" synapse" formation." However," at" a" later" time/point," Aβ42"
expressing"flies"showed"significant"decrease"in"the"total"synaptic"area"when"compared"to"
matching" controls" that" had" reached" 15" days." At" the" same" time," PI3K" flies" showed" a"
significant"increase"in"total"synaptic"surface,"in"concordance"with"previous"published"data"
(Martín/Peña" et" al," 2006)." Interestingly," PI3K" and" Aβ42" co/expression" showed" very"
significant"differences" compared" to"Aβ42" (Fig.!R1!A’/D’,E)." This" recovery" in" the" synaptic"
area"indicated"that"the"synaptogenic"effect"of"PI3K"could"prevent"the"synapse"loss"induced"
by"Aβ42"in"adult"motor"neurons"at"day"15"of"expression."PI3K/Aβ42"showed"no"significant"
changes" when" compared" to" control" flies," meaning" that" the" synapses" in" PI3K/Aβ42"
genotype"stayed"in"the"similar"values"than"control"healthy"flies.""
Observing" puncta" morphology," we" noticed" that" Aβ42" flies" showed" disorganized" non/
spherical"positive"dots"of"bruchpilot"signal" (Fig.!R1!C’)."This"deposit/like"morphology"was"
not" observed" in" any" of" the" other" genotypes," nor" in" 7" days" aged" Aβ42" flies" (Fig.! R1! A/
D,A’,B’,D’,A’’/D’’). 
""
4.2"PI3K!prevention!of!Aβ42<induced!synaptic!loss!is!age<independent"
Even"though"Aβ42"flies"died"soon"after"15"days"of"age"(at"29°C)"(Chapter"5),"we"wanted"to"
test"if"the"effect"of"PI3K/Aβ42"in"synapses"was"maintained"at"later"time/points"(Fig."R1!A’’/
D’’,E)." At" 25" days," PI3K" flies" maintained" significantly" larger" values" of" synaptic" area"
compared" to"matching"controls."At" this" time/point"PI3K/Aβ42"genotype"was" still" able" to"
keep" similar" values" of" synaptic" area" to" controls," and" no" significant" differences" were"
observed"between" the" two"groups." These" results" suggest" that" PI3K" expression"prevents"
Aβ42" synaptotoxic" effects" also" at" later" time/points." Taking" into" consideration" that"
PI3K/Aβ42" flies" died" under" these" conditions" soon" after" 25" days" (Chapter" 5)," we" can"
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conclude" that" PI3K" effects" in" preventing" Aβ42" synaptotoxicity" are" effective" in" an" age/
independent"manner."
Taking" all" these" results" together" (Fig.! R1)," we" confirm" that" Aβ42" expression" causes"
progressive"morphological"alterations"and"synapse" loss" in"adult"motorneurons,"and"have"
demonstrated"that"these"deleterious"effects"can"be"prevented"by"PI3K"activation."
""
4.3!Changes!in!synapses!are!not!due!to!transcriptional!regulation!"
In"order"to"investigate"the"molecular"mechanism"for"PI3K"rescue"of"Aβ42/induced"synapse"
elimination," we" wondered" first" if" the" transcription" of" synaptic" genes" was" affected."
Quantitative" RT/PCR" using" mRNA" from" adult" heads" was" used" to" analyzed" three" AZs"
components:"bruchpilot," liprin" and" synaptobrevin" (Kidokoro," 2003," Fouquet" et" al.," 2009)"
mRNA"levels."Flies"from"all"the"genotypes"in"the"study"were"aged"to"15"days"with"the"same"
adult/onset"design"used"in"previous"experiments.""
Our"qRT/PCR"results" indicated"that" there"are"no"significant"changes" in"mRNA"expression"
for"any"of"the"studied"genes"(Fig.!R2!A/C),"suggesting"that"PI3K"synaptic"restoration"is"not"
due"to"changes"in"transcription"of"the"synaptic"genes"bruchpilot,"liprin"or"synaptobrevin."
!
4.4!PI3K!prevents!the!Aβ42<induced!microtubule!dynamics!defects!
Since"Aβ42"can"alter"the"intracellular"transport,"we"wondered"if"PI3K"could"prevent"these"
alterations"as"a"mechanism"to"restore"synapses"(shown"in"Fig."R1)."""
To" this" end," we" performed" live" time/lapse" imaging" in" whole/mount" larvae" to" analyze"
microtubule" dynamics" using" the" UAS/EB1/GFP" construct." EB1" is" a" plus/end"microtubule"
binding"protein"that"reports"microtubule"dynamics"(see"Chapter"3"for"details)."Briefly,"EB1"
binds"to"the"plus/end"of"a"growing"microtubule,"but"detaches"from"shrinking"microtubules"
resulting"in"dynamic"GFP"signals"known"as"“comets”"(Fig.!R3!A)."
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EB1/GFP" comets"of" third" instar" larval" ddA" (dendritic" arborization"dorsal" cluster)" sensory"
neurons" were" recorded" under" a" microscope" equipped" with" a" spinning" disk." Length,"
duration,"velocity"and"density"of"EB1/GFP"comets"were"quantified"with"Imaris®"software."
Track"speed"in"PI3K"and"PI3K/Aβ42"genotypes"showed"significant"changes"when"compared"
to"controls,"but"no"statistical"significance"was" found" in"Aβ42."Furthermore,"no"statistical"
significance"was"observed"when"PI3K"and"PI3K/Aβ42"comets"were"compared" (Fig.!R3!B<
E,F)." Values" of" track" length" and" track" duration" did" not" change" in" any" of" the" studied"
genotypes"(Fig.!R3!G,H).""
Moreover," we" analyzed" track" density" by" counting" the" number" of" comets" relative" to"
dendritic" surface," as" the" EB1/GFP" overexpression" allows" some" background" signal" that"
serves" as" a" reporter" of" the" dendritic" size" (Fig.! R3)." Aβ42" expressing" neurons" showed" a"
significant" decrease" in" comet" density" compared" to" controls." Interestingly," PI3K" and"
PI3K/Aβ42" did" not" show" significant" changes" when" compared" to" controls" (Fig.! R3! I),"
indicating"that"PI3K/Aβ42"was"able"to"prevent"the"decrease"in"comet"density"induced"by"
Aβ42."
The" absence"of" significant" changes" in" track" length" and" track"duration" indicates" that" the"
growing"process"of"the"microtubule,"once"started,"is"affected"neither"by"Aβ42"nor"by"PI3K"
or"PI3K/Aβ42"expression"(Fig.!R3!G,H)."The"polymerization"of"tubulin"units"to"the"growing"
microtubule" appears" to" be" in" this" case," a" process" independent" of" Aβ42" or" PI3K"
overexpression."In"the"same"line,"the"speed"of"growing"processes"in"microtubules"appears"
to"be"independent"of"Aβ42,"but"can"be"affected"by"PI3K"or"PI3K/Aβ42"combined"(Fig.!R3!
F)."
We" conclude" from" these" findings" (Fig.! R3)" that" Aβ42" produces" changes" in"microtubule"
dynamics" by" reducing" the" number" of" growing" events" per" surface" unit,"which" is" a" direct"
evidence"of"intracellular"transport"deficits."Interestingly,"PI3K/Aβ42"neurons"had"the"same"
number"of"growing"microtubules"per"surface"unit"as"control,"pointing"that"PI3K"activation"
can" prevent"microtubule" dynamics" defects" induced" by" Aβ42," thus" allowing" a" functional"
intracellular"transport." "
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CHAPTER!5!! ! ANALYSIS!OF!LOCOMOTION!ACTIVITY!AND!SURVIVAL!EFFECTS!!
! ! ! OF!PI3K!OVEREXPRESSION!IN!Aβ42!INDUCED!! ! !
! ! ! NEURODEGENERATION!
!
The"promising" results" shown" in"chapter"4"urged"us" to" further"analyze" the"effect"of"PI3K"
overexpression" at" a" whole" organismal" level." In" other" Drosophila" AD" models,"
neurodegenerative"phenotypes"have"been"characterized"by"locomotion"performance"and"
lifespan"studies."In"order"to"compare"our"adult/onset"Aβ42"overexpression"model"with"the"
rest" of" AD" models" described," and" to" evaluate" if" PI3K" activation" can" protect," not" only"
synapses"morphology" but" also" their" function,"we" tested" the" locomotor" activity" of" adult"
flies"and"the"lifespan"of"the"4"genotypes"under"study."
"
5.1!Aβ42<induced!locomotion!activity!reduction!is!delayed!by!PI3K!overexpression!!
To" test" if" the" protected" synapses" were" functional" when" Aβ42" was" expressed" in"
combination"with"PI3K,"we"analyzed"locomotion"performance"in"adult"flies."
Three" different" groups" of" flies" were" annotated:" 1)" flies" that" reached" the" 4" cm" line"
threshold"within"the"given"time,"blue"histograms,"2)" flies"that"did"not"reach"this" line"but"
climbed"along"the"tube,"orange"histograms,"and"3)"flies"that"stayed"at"the"bottom"of"the"
tube,"black"histograms"(Fig.!R4!A)."
Results" showed" that" Aβ42" expressing" flies" developed" a" locomotor" activity" reduction" as"
soon"as"11"days"of"age,"appearing"for"the"first"time"in"this"study,"a"significant"group"of"flies"
that"stayed"at"the"bottom"of"the"tube"during"the"climbing"assay"(black"histograms)"(Fig.!R4"
D)."The"total"percentage"of"flies"that"could"not"climb"at"all"increased"progressively"as"the"
flies"aged,"and"this"proportion"of"flies"was"higher"than"50%"at"18"days"of"age"(Fig."R4!D)."
When" combined" with" Aβ42," PI3K" overexpression" delayed" the" appearance" of" the" non/
climbing"phenotype"to"15"days,"which"reached"50%"of"the"total"population"at"25"days"of"
age,"7"days"later"than"the"Aβ42"expressing"flies"(Fig.!R4!E)."
Control"and"PI3K"flies"did"not"show"any"sign"of"locomotor"deficits"until"30"days"of"age,"as"
expected"for"healthy"flies"grown"at"29°C"(Fig.!R4!B,C)."
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The" total" number" of" flies" that" climbed" above" the" line" was" reduced" in" Aβ42" flies" when"
compared" to" matching" controls" and" PI3K." This" effect" was" delayed" with" PI3K/Aβ42"
expression"(Fig.!R4!B/E)."
Pie"charts" for"15"days"and"20"days"data"show"more"specific"values" (Fig."R4!F/M)."As" the"
flies" aged," the" locomotor" affectation" became" more" evident" in" all" genotypes." Aβ42"
genotype" showed" a" very" rapid" reduction" of" the" climbing" performance" that" was" also"
aggravated" in" time." PI3K/Aβ42" genotype" developed" also" a" reduction" in" the" climbing"
performance"when" compared" to" controls," but" this" reduction"was" delayed" in" time"when"
compared"to"Aβ42"flies"(Fig.!R4)."
"
5.2!PI3K!expression!increases!lifespan!of!Aβ42!flies!!
Aβ42"is"known"to"affect"very"aggressively"the"organism"lifespan"when"expressed"with"pan/
neural" drivers" as" elav/Gal4" (Iijima" et" al.," 2004)," but" the" overexpression" of" PI3K" or" the"
combination"of"both"had"not"been"investigated"before,"so"we"studied"the"effect"of"these"
genotypes"with"the"same"adult/onset"design."
As"expected,"Aβ42"genotype"showed"a"significant"decrease"in"lifespan"when"compared"to"
control" (Fig.! R5! B)." On" the" other" hand," PI3K" overexpression" alone" showed" significant"
increase"in"survival"(Fig!R5!A)."PI3K"overexpression"when"combined"to"Aβ42,"significantly"
ameliorated" the" negative" lifespan" effect" attributed" to" Aβ42" (Fig.! R5! D)." However," this"
recovery" in" survival" did" not" reach" control" values," and" significant" differences" were"
observed"when"PI3K/Aβ42"was"compared"to"controls"(Fig.!R5!C)."
Taken"together," these"data" (Fig.!R5)" indicate"that"PI3K"overexpression"ameliorates"Aβ42"
lifespan"reduction."The"recovery" in"survival,"although"very"significant"when"compared"to"
Aβ42," does" not" reach" lifespan" values" of" control" flies." Moreover," PI3K" alone" showed"
significant"increase"in"lifespan"in"comparison"with"controls"(Fig.!R5!E)."
"
!5.3!PI3K!in!human!neurons!prevents!the!cell!survival!reduction!induced!by!Aβ42!"
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Knowing" that" PI3K" synaptogenic" actions" are" conserved" in" human"neurons," and" that" our"
Drosophila"AD"model" is"based" in"human"Aβ42"expression,"we"wondered" if" the"effect"of"
PI3K"preventing"Aβ42"neurodegeneration"was"also"conserved."
To"examine"if"the"effects"of"PI3K"in"neurons"exposed"to"Aβ42"oligomers"were"reproduced"
in"human"cells,"we"cultured"the"human"neuroblastoma"cell"line"SH/SY5Y.""
Cells" were" grown" and" differentiated" with" retinoic" acid" and" 1%" serum" for" 48h" prior" to"
stimulation" with" treatments." Once" differentiated," neurons" were" treated" with" Aβ42"
oligomers."As"expected,"treatment"with"Aβ42"oligomers"/"reduced"viability"after"48"hours."
To" stimulate" PI3K" activity" in" these" cells" and" evaluate" cell" viability,"we" used" the" peptide"
PTD4/PI3KAc,"which"was"previously"proved"to"trigger"PI3K"activation"both" in"vitro"and"in"
vivo" (Cuesto" et" al.," 2011," Enriquez/Barreto" et" al.," 2014)." PTD4/PI3KAc" peptide" was"
administered" at" 3" different" time" points," naming" the" 3" time/point" treatments" as" 1)" pre/
treatment," 24h" before" Aβ42," 2)" co/treatment," at" the" same" time" as" Aβ42" and" 3)" post/
treatment,"24h"after"Aβ42."
Aβ42"oligomers"where"prepared" following"Kayed"&"Gable,"2006"protocol" (see"chapter"3"
for" details)" and" added" to" the" cell" culture" 72" hours" after" cell" seeding" (48" hours" after"
differentiation)," at" 3" different" concentrations," to" study" the" potential" effects" of" PI3K"
activation"under"these"conditions."
The" percentage" of" cells" alive" after" the" treatment"with" Aβ42" oligomers"was" significantly"
decreased" when" Aβ42" peptide" concentration" was" 36μg/ml" or" 72μg/ml," compared" to"
control"cells."These"results"confirmed"the"acuity"of"the"oligomer"preparation"protocol"and"
were"used"as"positive"internal"controls"in"the"experiment"(Fig.!R6)."
As"expected,"Aβ42"oligomers"did"not"affect"cell"viability"at"low"concentrations"(18μg/ml).""
PTD4/PI3KAc"peptide"administration"produced"no"significant"changes"in"cell"viability"when"
the" treatment" occurred" 48h" or" 72h" after" differentiation," but" produced" a" significant"
increase" in" viability" when" administer" 24h" after" differentiation." This" effect" can" be"
attributed" to" the"brief" period"of" starvation" and"differentiation" that" the" cells" had" at" this"
moment" (24h)" that" could" allow" cells" to" respond" to" mitogen" stimuli," like" PI3K" pathway"
effectors."
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Results"from"the"viability"Cell"Titer"assay"showed"that"PI3K"activation"could"prevent"Aβ42/
induced" cell" death" when" administer" either" before" or" at" the" same" time" than" Aβ42"
oligomers," if" the" concentration" of" oligomers"was" 36μg/ml." No" protection"was" found" at"
higher"concentrations"(72μg/ml)"(Fig.!R6)"
Together,"these"data"indicate"(Fig.!R6)"that"PI3K"activation"can"protect"cell"viability"from"
Aβ42"oligomers"toxic"effect" in"human"neurons."This"protection"can"be"achieved" if"PTD4/
PI3KAc"peptide"was"added"24"hours"before"Aβ42"treatment,"or"at"the"same"time"as"Aβ42"
treatment,"when"oligomers"concentration"was"36μg/ml."
"
" "
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CHAPTER!6!! ! STUDY!OF!THE!SYNAPTOGENIC!ACTIONS!OF!MEDEA!! !
! ! ! DOWN<REGULATION!AND!mTOR!OVEREXPRESSION!IN!Aβ42!!
! ! ! NEURODEGENERATION!
!
Activation"of"PI3K"proved" to"prevent"Aβ42/induced"synapse" loss"and"delayed" locomotor"
performance" deficits," as" well" as" ameliorated" longevity," as" shown" in" bruchpilot"
quantification"in"adult"NMJs,"climbing,"and"lifespan"assays,"respectively."Furthermore,"SH/
SY5Y" cells" were" also" protected" from" Aβ42/induced" cell" death"when" PI3K"was" activated"
before"or"together"with"Aβ42"treatment."
Being" PI3K" at" the" crossroads" of" many" pathways," one" could" argue" that" the" preventive"
effects"shown"by"the"overexpression"of"this"kinase"could"be"explained"by"the"activation"of"
the" canonical" pathway" of" PI3K," that" is" known" to" elicit" pro/survival" and" cell" growth"
responses."Thus,"we"wondered"if"classical"effectors"of"PI3K"pathway"could"reproduce"the"
protective" functions" of" PI3K," or" if" on" the" other" hand," more" synaptogenic" proteins"
previously" proved" to" increase" synapse" number," could" attain" the" preventive" actions" of"
PI3K."
"
6.1! Synaptogenic! proteins,! but! not! canonical! PI3K! effectors,! prevent! Aβ42<induced!
synapse!loss!!
To"explore" the"PI3K"partners" in" the"neuroprotective"effect"against"Aβ42," synapses"were"
quantified"when"mammalian"Target"of"Rapamycin"(mTOR),"a"downstream"protein"of"the"
canonical"pathway"of"PI3K/Akt,"was"overexpressed."mTOR,"does"not"exhibit"synaptogenic"
effects" when" overexpressed" in" Drosophila" NMJs" (Martín/Peña" 2007)," and" thus" is" not"
considered"a"player"in"the"synaptogenic"pathway."Using"the"same"procedure"as"in"Chapter"
4.1,"the"total"bruchpilot"signal"was"quantified"from"adult"abdominal"NMJs"of"15"days/old"
flies." This" is" a" time/point"where" PI3K" synaptogenic" effect"was" first" observed." Like" in" all"
previous"experiments,"the"pan/neural"elav/Gal4"driver"was"used"under"the"Gal80ts"control,"
allowing"the"expression"of"the"corresponding"UAS"constructs,"only"after"fly"eclosion."
Results"showed"that"mTOR"overexpression"(Fig.!R7!B,E,G)"was"not"able"to"prevent"Aβ42"
synapto/toxicity,"as"we"found"a"very"significant"decrease"in"synapse"surface"in"mTOR/Aβ42"
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(Fig.!R7!E,G)"NMJs"compared"to"controls."When"overexpressed"alone,"mTOR"(Fig.!R7!B,G)"
showed"no"significant"differences"in"the"active"zones"quantification"compared"to"controls,"
confirming"previous"reports."
Synapse" surface" was" also" evaluated" with" Medea" down/expression." Medea" is" an" anti/
synaptogenic"protein,"homolog"of"human"Smad"4""(Hudson"et"al.,"1998),"that"binds"to"Mad"
and," together," regulate" gene" transcription." It" acts" downstream" of" PI3K," and" is" directly"
inhibited"by"the"E3/Ubiquitin"ligase"Hiw"(Highwire),"which"can"bind"to"Medea"and"cause"its"
degradation"impeding"NMJ"growth"(McCabe"et"al.,"2004)."
On"the"other"hand,"MedeaRNAi"in"combination"with"Aβ42"(Fig.!R7!F)"prevented"the"synapse"
loss" (Fig.! R7! D)," as" we" found" no" significant" differences" between" MedeaRNAi/Aβ42" and"
control,"while"there"was"very"significant"differences"when"compared"to"Aβ42""(Fig!R7!G)."
MedeaRNAi,"when"expressed"alone"(Fig.!R7!C)"did"not"show"significant"changes"in"synapses"
(Fig.!R7!A,C,"G)."
These" observations" (Fig.! R7)" indicate" that" MedeaRNAi," but" not" mTOR," prevents" Aβ42/
induced" synaptotoxicity."Medea" down/expression" alone" did" not" affect" synapse" surface,"
but"mTOR"produced"a"very"significant"decrease"in"synapse"values."
!
6.2!Aβ42<induced!locomotor!decline!is!prevented!by!Medea!knockdown!!
The"promising"results"extracted"from"the"NMJ"active"zones"quantification"shown"by"Aβ42"
in" combination"with"MedeaRNAi" urged" us" to" analyze" the" functionality" of" these" flies" in" a"
locomotor"assay."
The" same"procedure"used" in"Chapter"5.1"was"applied" to"mTOR,"mTOR/Aβ42,"MedeaRNAi"
and"MedeaRNAi/Aβ42"genotypes"(Fig.!R8!A)."
The" results" showed" a" reduction" in" the" climbing" performance" of"mTOR/Aβ42" flies"when"
compared"to"controls"(Fig.!R8!H,B)."Also,"we"found"that"flies"started"to"show"a"no/climbing"
phenotype,"and"stayed"at"the"bottom"of"the"tube,"as"early"as"9"days"of"expression"(black"
histograms"in"Fig.!R8!H)."mTOR"overexpression"alone,"also"showed"a"reduction"in"the"total"
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number"of" flies"reaching"the"4cm"line"(Fig.!R8!E),"with"flies"staying"at"the"bottom"of"the"
tube"at"15"days"of"expression."
On"the"other"hand,"MedeaRNAi/Aβ42"combination"showed"no"differences"when"compared"
to"control"flies"in"any"of"the"three"populations"counted:"above"the"4"cm."line,"below"the"4"
cm."line,"and"at"the"bottom"of"the"tube"(Fig.!R8!B,M)."MedeaRNAi"alone"showed"a"climbing"
phenotype,"as"expected"because"of"its"role"in"synapse"number"regulation"(Fig.!R8!B,"J)."
Taken" together" these" data" (Fig.! R8)" indicate" that" other" synaptogenic" agents," such" us"
down/expression" of" Medea" prevent" the" deterioration" of" the" locomotor" performance"
characteristic"of"Aβ42"toxicty."By"contrast,"this"is"not"the"case"for"classical"effectors"of"the"
PI3K"pathway"like"mTOR."
!
6.3!Medea!knockdown!prevents!Aβ42<induced!lifespan!reduction!!
Already" known" the" longevity" effects" of" PI3K" in" Aβ42" flies," we" wondered" if" mTOR"
overexpression"or"Medea"down/expression"could"also"be"affecting"Aβ42"flies"lifespan."
To"address"this" issue,"survival"studies"were"conducted"following"the"same"protocol"as" in"
Chapter" 5.2," this" time" with" mTOR," mTOR/Aβ42," MedeaRNAi" and" MedeaRNAi/Aβ42"
genotypes."
The" analysis" of" the" survival" curves" demonstrated" a" significant" decrease" in" lifespan" in"
mTOR/Aβ42"flies,"as"well"as"in"mTOR"overexpression"alone"(Fig.!R9!A,B)."When"compared"
to"Aβ42"flies,"mTor/Aβ42"group"showed"a"significant"decrease"(Fig.!R9!E)" indicating"that"
mTOR"could"act"as"an"enhancer"in"lifespan"reduction"by"Aβ42."
MedeaRNAi/Aβ42," on" the" other" hand," blocked" the" Aβ42" reduction" effect" in" lifespan,"
showing"no"significant"differences"when"compared"to"control"flies"(Fig.!R9!D)."MedeaRNAi"
alone" demonstrated" no" significant" differences" either" (Fig.! R9! C)." Comparing" Aβ42" and"
MedeaRNAi/Aβ42"lifespan"we"found"a"very"significant"increase"(Fig.!R9!F),"as"expected"from"
previous"comparisons"of"MedeaRNAi/Aβ42"with"control"flies."
These" results" (Fig.! R9)" indicate" that" Medea" down/expression," a" synaptogenic" tool,"
abolishes"the"lifespan"limiting"effect"of"Aβ42"expressing"flies."On"the"opposite"side,"mTOR"
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overexpression,"a"downstream"activation"of"PI3K/Akt"canonical"pathway,"cannot"prevent"
Aβ42"toxicity,"but"rather"accentuates"it."
Experiments"of"synapse"quantification"(Fig.!R1"&"Fig.!R7),"climbing"performance"(Fig.!R4!&"
Fig.!R8)"and"survival"(Fig.!R5"&"Fig.!R9)"have"tested"the"ability"of"Medea"down/expression"
and" PI3K" overexpression," two" synaptogenic" strategies," to" counteract" the" degenerative"
effects" of" Aβ42." Both" proteins," previously" proved" to" upregulate" synapse" growth," have"
demonstrated" to"effectively"decrease" the"synapto/toxicity"produced"by"Aβ42,"allowing"a"
better"locomotor"performance"and"increasing"lifespan."
"
" "
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CHAPTER!7!! ! ANALYSIS!OF!A!NOVEL!EFFECT!OF!PI3K!IN!Aβ42!AGGREGATION!
!
As" described" in" Chapter" 1," a" key" feature" in" AD" pathology" is" Aβ42" accumulation," which"
exponentially" increases"during"the"preclinical"phase."Excessive"accumulation"of"Aβ42"can"
lead"to"oligomer"formation."Oligomers"are"the"most"toxic"species"of"β/amyloid,"as"they"are"
known"to"directly"affect"synapses,"and"they"can"suffer"modifications"such"as"truncations,"
isomerization"and/or"phosphorylations"that"alter"oligomerization"and"aggregation."
Being"Aβ42"levels"critical"for"the"progression"and"outcome"of"the"pathology,"we"wondered"
if" PI3K" preventive" actions" in" synapses" had" any" effect" on" Aβ42" accumulation" or"
aggregation."
"
7.1!PI3K!activation!increases!Aβ42!levels!without!affecting!transcription!!
To"understand"the"effect"that"PI3K"could"be"causing"in"Aβ42"accumulation,"we"analyzed"by"
immunohistochemistry"the"total"signal"of"Aβ42"in"15"days/old"brains"using"the"commonly"
used"6E10"antibody."This"antibody"recognizes"the"N/terminus"of"the"amyloid"peptide."As"
this" epitope" is" not" found" in" APLP" Drosophila" protein," no" signal" is" expected" in" control"
brains."
Aβ42"adult"brains"(Fig.!R10!A/D)"showed"a"noticeable"positive"signal"for"6E10,"which"was"
completely"absent"in"control"or"PI3K"overexpressing"brains"(Fig.!R10!A,B)."Surprisingly,"this"
positive"signal"was"increased"and"expanded"in"PI3K/Aβ42"brains"(Fig.!R10!C,D)."
To" confirm" this" result," same"aged" adult" heads" homogenates"were" analyzed"by"Western"
blot" (Fig.! R10! E)." Quantification" of" the" total" Aβ42" protein" showed" " 2.5" fold" increase" in"
PI3K/Aβ42"compared"to"Aβ42"alone."
In" order" to" investigate" a" putative" effect" in" transcription," qRT/PCR" was" performed" with"
same" aged" adult" head" homogenates" and" the" results" showed" no" changes" in" total" Aβ42"
mRNA,"discarding"this"possibility"(Fig.!R10!F)."
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Therefore," these" data" indicate" (Fig.! R10)" that" PI3K" overexpression" causes" a" total" Aβ42"
protein" increase," demonstrated" by" immunostaining" and"Western/blot,"without" affecting"
its"transcription"levels,"as"analyzed"by"quantitative"RT/PCR."
"
7.2!PI3K!overexpression!increases!Aβ42!insoluble!fraction!"
Being"aware"that"different"Aβ"aggregation"assemblies"can"lead"to"very"different"scenarios"
(Fig.!R11!A),"we"postulated"the"hypothesis"that"the"increase"in"total"Aβ42"protein"found"in"
PI3K/Aβ42,"could"be"explained"by"having"a"higher"proportion"of" insoluble,"and" thus" less"
toxic,"aggregates."
To"prove"this"hypothesis"we"stained"7"and"15"days/old"brains"with"Thioflavin/S"(Fig.!R11!B/
C’)," a" dye" that" specifically" binds" to" proteins" with" β/sheet" conformation." The" dye" labels"
Aβ42" fibers" and" plaques" that" constitute" the" insoluble" fraction" of" β/amyloid" aggregates."
Quantification"of"the"positive"Thioflavin/S"signal"demonstrated"a"significant"increase"in"the"
insoluble"fraction"of"Aβ42"deposits"at"15"days"of"age"in"the"PI3K/Aβ42"brains"compared"to"
age/matched"Aβ42"alone"(Fig.!R11!E)."
This"result"was"confirmed"by"Western/blot"of"insoluble"protein"extractions"from"15"days/
old"adult"heads."The"quantification"showed"a"4/fold" increase" in" the" insoluble" fraction"of"
Aβ42"in"PI3K/Aβ42"genotype"(Fig.!R11!D)."
Taken"together,"these"data"(Fig.!R11)"confirm"the"hypothesis"that"PI3K"triggers"a"change"in"
Aβ42"aggregation"into"a"more"insoluble"species.""
"
7.3!PI3K<induced!Aβ42!aggregation!changes!are!reproduced!in!human!neurons!
Having" previously" proved" that" PI3K" activation" can" prevent" Aβ42/induced" cell" death,"we"
wondered" if" the" aggregation" effect" that" PI3K" elicits" in" Aβ42" conformers" could" also" be"
reproduced"in"human"neurons.!
To"assess"that,"we"cultured"and"differentiated"human"neuroblastoma"cells"(SH/SY5Y)"with"
retinoic" acid" and" 2%" serum" for" 48h" prior" to" stimulation" with" the" treatments." Once"
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differentiated," neurons" were" treated" with" Aβ42" oligomers" (36μg/ml)" and" PTD4/PI3KAc"
peptide"(50μg/ml)"(see"Chapter"3"for"details)."Cover/slides"were"used"in"the"seeding"plates"
to" later" perform" immunostainings" with" 6E10" antibody." Cells" were" treated" with" both"
stimuli"added"at"the"same"time"and"incubated"for"48h."Afterwards,"cells"were"fixed"with"
formaldehyde" 4%" following" a" standard" protocol" of" immunostaining" (Fig.! R.12! A)." 6E10"
positive" deposits" were" counted" and" surface" per" deposit" was" measure" with" the" Imaris"
software."
As"expected,"no"6E10"positive"deposits"were"found"in"cells"treated"either"with"vehicles"or"
with" PTD4/PI3K" alone" (Fig.! R12! E/F’)." For" practical" reasons" only" Aβ42" and" PTD4/
PI3KAc/Aβ42"experiments"were"compared"(Fig.!R12!G/H’)."
PTD4/PI3KAc" in" combination" with" Aβ42" oligomers" treatment," showed" a" significant"
decrease"when"comparing"the"total"number"of"deposits"found"in"Aβ42"treatment"(Fig.!R12!
B)." Interestingly," the" total" surface" of" deposits" did" not" change" between"Aβ42" treatment"
and" PTD4/PI3KAc" +" Aβ42" treatment" (Fig.! R12! C)." However," deposit" surface" distribution"
showed" that" in"PTD4/PI3KAc"+"Aβ42" treatment" there"were"bigger"deposits" that"differed"
from"Aβ42"treatment"by"threefold,"fourfold"and"even"six"fold"increase"in"size"(Fig.!R12!D)."
These"data"(Fig.!R12)"indicate"that"the"Aβ42"aggregative"properties"shown"by"PI3K"in"adult"
flies" are" reproduced" in" human" SH/SY5Y" neurons," where" the" peptide" PTD4/PI3KAc" can"
induce"three"to"six"fold"increase"in"the"deposit"size."!
!
7.4!PI3K<induced!changes!in!Aβ42!aggregation!can!be!reproduced!outside!of!cells"
To"further"analyze"the"aggregation"effect"that"PI3K"activation"triggers"in"Aβ42"oligomers,"
and"to"test"if"these"actions"could"take"place"in"the"extracellular"space,"were"the"majority"of"
deposits" are" generated," we" designed" a" set" of" experiments" to" decipher" if" PTD4/PI3KAc"
peptide"was"indeed"capable"to"promote"Aβ42"aggregation"extracellularly."
Following" a" previously" described" protocol," human" neuroblastoma" cells" (SH/SY5Y)" were"
cultured"with" retinoic" acid" and" 2%" serum" for" 48h" prior" to" stimulation"with" treatments."
Once" differentiated," neurons" were" treated" with" Aβ42" oligomers" (36μg/ml)" and" PTD4/
PI3KAc"peptide"(50μg/ml)"(see"Chapter"3"for"details)."
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Four" different" culture" classes" were" designed:" 1)" internal" control" for" Aβ42" oligomers"
aggregation,"2)"Aβ42"oligomers"with"PTD4/PI3KAc"pre/treatment,"3)"Aβ42"oligomers"with"
PTD4/PI3KAc" co/treatment," and" Aβ42" oligomers" with" PTD4/PI3KAc" post/treatment" (Fig.!
R13! A)." Supernatants" were" stained" with" 6E10" antibody," and" analyzed" with" Imaris"
software."
The" internal" control" of" Aβ42" oligomers" showed" no" significant" 6E10" positive" deposits,"
meaning"that" in" the"given"time"of"48h,"extracellular"aggregates" that"could"be"generated"
were"not"detected."
When"total"number"of"deposits" in" the"PTD4/PI3K"pre/treatment,"co/treatment"and"post/
treatment"experiments"was"measured,"(Fig.!R13!B)"we"found"no"significant"differences"in"
any"of"the"experiments."Moreover,"similar"negative"results"appeared"when"the"total"area"
of"deposits"was"compared"among"the"three"experiments"(Fig.!R13!C)."
However," the"three"experiments"showed"significant"differences"when"the"ratio"“number"
of" deposits/deposit" area”" was" studied" (Fig.! R13! D)." When" more" detailed" analysis" was"
performed," in"order" to"evaluate" the"deposit" surface"distribution" (Fig.!R13!E)," PTD4/PI3K"
co/treatment"showed"a"twofold,"fourfold"or"even"a"ten/fold"increase"in"deposit"size,"when"
compared" to" PTD4/PI3KAc" pre/treatment" and" post/treatment." PTD4/PI3KAc" post/
treatment"showed"the"smallest"deposits"among"the"three"experiments"of"the"study"(Fig.!
R13!E)."
Taken"together,"these"data"indicate"that"PTD4/PI3KAc"peptide"promotes"Aβ42"aggregation"
extracellularly"(Fig.!R13)."This"increase"in"aggregation"upon"PI3K"treatment"leads"to"larger"
Aβ42" deposits" that" range" from" two" to" ten/fold" increments" in" size." These" findings" also"
suggest" that" PTD4/PI3KAc" co/treatment" is" the" most" aggregative" strategy" for" Aβ42"
oligomers."
"
7.5!pSer<Aβ42!increases!following!PI3K!overexpression!"
Knowing" that" phosphorylation" has" been" documented" to" be" one" of" the" factors" that" can"
affect"Aβ42"seeding"in"the"initial"phase"of"the"plaque"formation,"we"argue"that"PI3K"kinase"
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activity" could" be" directly" affecting" this" phosphorylation" and" thus" inducing" Aβ42" plaque"
seeding."
To" test" this" hypothesis," we" looked" for" residues" suitable" to" be" phosphorylated" in" Aβ42"
according" to" the" NetPhos" 2.0" Server" prediction" software" (www.cbs.dtu.dk)." This" study"
suggested" 3" putative" residues:" pSer8" (Score:" 0.963)," pTyr10" (Score:" 0.870)" and" pSer26"
(Score:"0.787)"(Fig.!R14!A)."
Phospho/Tyrosine"and"phospho/Serine"specific"antibodies"were"used"in"15"days/old"brains"
in" order" to" analyze" changes" in" the" signal" in" the" four" genotypes" under" study." Confocal"
images"(Fig.!R14!B/E’)"indicated"that"only"in"PI3K/Aβ42"brains"(Fig.!R14!E,E’)"the"phospho/
Serine" signal" was" incremented." Interestingly," the" phospho/Serine" signal" in" PI3K/" Aβ42"
brains" had" deposit/like" morphology." Phospho/Tyrosine" signal" was" very" similar" in" all"
genotypes"and"no"deposit/like"morphology"was"found"(Fig.!R14!F/I’)."
Co/localization"of"6E10"and"both"phospho/Serine"and"phospho/Tyrosine"was"not"feasible"
due" to" the" requirement" of" formic" acid" for" 6E10" immunostaining," which" strongly" alters"
phospho/peptides"and"membrane"stability"(data"not"shown)."
We" can" conclude" from" these" results" (Fig.! R14)" that" PI3K" overexpression" in" an" Aβ42"
background"drives"the"accumulation"of"phospho/Serine"positive"deposits.""
!
7.6!PI3K!specifically!triggers!Ser26<Aβ42!phosphorylation!!
The" NetPhos" 2.0" Server" predicts" two" different" serine" residues" that" could" become"
phosphorylated." Thus," we" took" advantage" of" the" recently" developed" and" kindly" gifted"
pSer8/Aβ42"and"pSer26/Aβ42"antibodies,"by"Dr."Jochen"Walter"lab"(Kumar"et"al,"2013)"and"
performed"immunostainings."
No"changes"were"found"in"pSer8/Aβ42"immunostainings"in"Aβ42"or"PI3K/Aβ42"genotypes"
(Fig.! R15! A’’,B’’)." Phospho/Ser26/Aβ42" immunostainings" showed" deposits" with" positive"
signal"in"both"Aβ42"and"PI3K/Aβ42"(Fig.!R15!A’,B’)."Unfortunately,"pSer26/Aβ42"antibody"
could"not"give"direct" results"due" to" the" fact" that" it" can"detect"both"phosphorylated"and"
non/phosphorylated"Aβ42."
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Taken" together," these" data" (Fig.! R15)" indicate" that" PI3K" does" not" trigger" the"
phosphorylation" of" Aβ42" in" residue" serine" 8," proved" by" immunostaining" with" the" only"
specific" antibody" available" at" this" time," and" thus," having" proved" before" that" PI3K"
generates"phospho/serine"positive"deposits,"and"that"there"are"only"two"potential"serine"
residues"in"Aβ42,"a"phosphorylation"in"pSer26/Aβ42"seems"plausible.""
"
"
"
"
"
"
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CHAPTER!8!! ! CHARACTERIZATION!OF!Aβ42!PHENOTYPES!IN!NON<NEURONAL!!
! ! ! TISSUES!AND!STUDY!OF!PI3K!EFFECT!IN!THESE!ENVIRONMENTS!
!
Although"it"is"not"fully"understood"today"whether"extracellular"or"intracellular"β/amyloids"
are"the"first"toxic"Aβ"species,"it"is"widely"accepted"that"Aβ42"accumulations"can"aggregate"
in"extracellular"spaces."Moreover,"the"two"models"used"in"this"study"can"mimic"this"type"of"
accumulations," as" the"UAS/Aβ42"construct" consists"of" two" tandem"copies"of" the"human"
Aβ42" sequence" fused" to" a" peptide" signal" for" secretion," and" the" Aβ42" oligomers" were"
added" extracellularly" to" HT/SY5Y" cultured" cells," allowing" in" both" scenarios" extracellular"
circulation"and"aggregation"of"Aβ"species."
In"this"work,"we"have"demonstrated"the"PI3K"preventive"actions"of"Aβ42"synaptotoxicity,"
and"moreover,"the"effects"of"PI3K"in"Aβ42"aggregation,"both"in"human"in*vitro"studies"and"
in"Drosophila*in*vivo*analysis."However,"being"aware"that"Aβ42"can"diffuse,"circulate"and"
eventually" reach" other" types" of" cells" that" could" become" sensitive" to" Aβ42" toxicity," we"
wondered"if"1)"Aβ42"expression"could"affect"non/neuronal"cells,"and"if"2)"PI3K"activation"
could"also"prevent"the"potential"Aβ42/induced"toxicity"in"these"non/neuronal"contexts."
In"this"chapter"we"evaluated"Aβ42"toxicity"in"neuro/secretory"cells"and"epithelial"cells,"and"
checked" if"PI3K" co/expression"could"prevent" these"potential"deleterious"effects." For" this"
purpose"we" characterized" in"detail" the"expression"domains"of" two"drivers,"elav/Gal" and"
D42/Gal4,"along"development"in"epithelial"cells"of"the"wing"disc."
!
8.1!Aβ42<induced!inflated!abdomen!phenotype!is!prevented!by!PI3K!overexpression"
To" our" surprise," adult" flies" overexpressing" Aβ42" with" the" pan/neural" elav/Gal4" driver,"
together"with" the" temperature" sensitive"Gal80ts" construct,"which" allowed" expression" of"
the"UAS/Aβ42"only"after"adult"eclosion,"showed"a"largely"inflated"abdomen"as"they"aged"
(Fig.! R16!A,B)." To" our" knowledge," this" is" the" first" report" of" Aβ42" causing" an" abdominal"
phenotype" in" flies."We"also"observed" that" the" flies"presented"not/retractable"proboscis,"
and"that"this"phenotype"did"not"appear" in"PI3K/Aβ42"flies"(Fig.!R16!C)."By"contrast,"PI3K"
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and"PI3K/Aβ42"flies"showed"no"abdomen" inflation" (Fig.!R16!A)."These"data" indicate"that"
PI3K"can"restore"the"abdomen"volume"inflation"and"the"loss"of"proboscis"retraction"caused"
by"Aβ42"(Fig.!R16!A<C)."
Knowing"that"a"very"similar"phenotype"is"caused"by"irregular"secretion"due"to"blockade"of"
the"secretory"system" in" flies,"we"wondered" if" this"could"be"the"case" for"Aβ42."To"assess"
that,"we"overexpressed"Aβ42"in"abdominal"leucokinergic"cells"(leucokininM7/Gal4),"a"set"of"
peptidergic" neuro/secretory" cells" that" extend" their" projections" to" the" CNS" and" the"
periphery," where" they" reach" abdominal" muscle" 8." The" terminals" of" these" cells" do" not"
present"bouton/like"structures"and"they"lack"synapsin"and"sybsynaptic"reticulum"(Landgraf"
et"al.,"2003)."
The" overexpression" of" Aβ42" in" leucokinin" cells" reproduced" the" increase" in" abdominal"
volume"previously"described"with"elav/Gal4"driver"(Fig.!R16!D,E)."Furthermore,"PI3K/Aβ42"
combination"prevented"the"inflation"phenotype"(Fig.!R16!D,E)."The"loss"of"retraction"in"the"
proboscis" of"Aβ42" flies"was" also"observed"with" leucokinin/Gal4" driver," and" akin" to" elav/
Gal4,"PI3K/Aβ42"prevented"this"effect"(Fig.!R16!F)."These"observations"suggest"that"Aβ42"
can" cause" deleterious" effects" in" cells" lacking" regular" synapses," like" leucokinin" neuro/
secretory"cells,"and"that"this"phenotype"can"be"restored"by"PI3K"overexpression"(Fig.!R16)."
The"surprising"observation"of"Aβ42"effects" in"non/neuronal"cells,"made"us"wonder"about"
the"possibility"that"other"non/neuronal"tissues"could"also"be"sensitive"to"Aβ42"toxicity."
However," the" elav/Gal4" expression" domain" with" which" the" non/neuronal" Aβ42"
phenotypes"were"identified"was"at"odds"with"the"widely"accepted"neuronal"specificity"of"
this"driver."To"address" this" contrast,"we" re/examined" in"detail" the"expression"domain"of"
this"driver.""
"
8.1.1!The!nervous!system!enhancer!elav!is!transiently!active!in!epithelial!cells"
The" Drosophila" gene" elav," orthologue" of" ELAVL" gene" family" in" humans," is" expressed"
throughout"the"brain"(Robinow"and"White,"1988,"Van"Tine"et"al.,"1998,"Han"et"al.,"1996,"
Muresu" et" al.," 1994," Robinow" and"White," 1991)."We" confirmed" the" reported" elav/Gal4"
expression"in"brain"neurons"(Figure!R17!A,A’)"with"the"G/TRACE"system,"which"reports"the"
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temporal"activation"of"the"enhancer/Gal4"under"study"(Chapter"3"for"details)."The"current"
(red" positive" cells)" and" historical" (green" positive" cells)" records" of" elav*enhancer" activity"
showed"high"correspondence"between"both"signals."These"data"indicate"that"cells"fated"to"
be"neurons" in" the"brain"are"determined"during"development"and"this" fate" is"maintained"
during"CNS"development."
Further,"we"analyzed"epithelial"tissues"to"determine"the"specificity"of"this"elav*enhancer."
The"data"showed"widespread"positive"green"cells"(Figure!R17!B)"and"randomly"distributed"
red"positive"cells" in"wing"imaginal"discs"(Figure!R17!B’)."These"red"(RFP)"and"green"(GFP)"
signals" demonstrate" that" the" elav" enhancer" had" been" expressed" in" wing" disc" cells"
sometime"along"development."
To"determine"at"what"stage"during"development"this"ectopic"enhancer"activation"occurs,"
we"analyzed"1st" and"2nd" instar" larvae"wing"discs" (24" and"48"hours" after" egg" laying,"AEL)"
(Figure!R17!C/D’)."G/TRACE"reporters"showed"that"the"elav"enhancer"was"active"as"early"as"
1st"(Figure!R17"C,C’)"and"2nd"(Figure!17!D,D’)"instar"larvae."Red"and"green"cells"are"found"in"
the" wing" disc" suggesting" that" the" enhancer" activity" is" triggered" at" the" initial" stages" of"
development."
Together," these"results" indicate"that"the"elav"enhancer" is"active" in"epithelial"cells"during"
development"and"maintains"its"activity"by"the"third"larval"instar,"albeit"to"a"lesser"extent,"
as" RFP/positive" cells" are" less" numerous" than" GFP/positive" cells" (Fig.! R17! A/D’)." GFP/
positive"cells" represent" the"wing"disc"cells"where" the"enhancer"has"been"active"at" some"
point" during" development," but" has" eventually" become" inactive." RFP/positive" cells"
represent" the" wing" disc" cells" where," at" the" moment" of" dissection," elav" enhancer" was"
active.""
We" noticed" that" the" expression" pattern" of" GFP" and" RFP" cells" across" different" discs" of"
different" larvae" was" not" reproducible." Although" this" variability" could" result" from"
heterogeneous" environmental" conditions" among" individuals," we" further" evaluated" this"
feature"comparing"left"and"right"wing"discs"from"the"same"individual."The"number"of"GFP/
positive" cells"was" comparable"between" the" two"wing"discs"of" the" same"animal," yet," the"
pattern"differs"(Figure!R17!E/F,G)."Moreover,"we"compared"left"and"right"wing"discs"of"the"
elav/Gal4" inserted" in" another" chromosome" (Chr.II)," in" order" to" check" if" the" ectopic"
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activation"of"the"classical"neuronal"enhancer"elav"was"affected"by"the"insertion"locus"(Fig.!
R17!H,I)."In"this"case,"we"also"found"strong"variability"in"GFP/positive"cells"when"comparing"
left" and" right" wing" discs," and" no" RFP/positive" cells" were" detected." GFP" and" RFP" cells"
patterns"differed"also"when"we" compared"elav/Gal4"enhancer" inserted" in"Chr." III" versus"
elav/Gal4"in"Chr."II."(Fig.!R17!E/I,"J)."
This" result" (Fig.! R17! E/J)" supports" the" notion" that" the" elav" enhancer" activation" during"
development" is" not" a" deterministic" phenomenon" and" it" rather" appears" to" be" a" random"
process.""
Finally,"to"determine"if"the"ectopic"wing"disc"expression"of"the"elav*enhancer"induces"the"
expression"of"Elav"protein,"we"stained" larval" tissues"with"anti/Elav"antibody."Third" instar"
larval"brains"showed"that"elav"enhancer"is"active"in"neurons"as"expected"(Figure!17!K)"and"
brain" cells" express" Elav" protein" (Figure! 17! K’)." However," while" wing" discs" show" elav"
enhancer"activity"(Figure!17!L),"the"Elav"protein"staining"was"negative"(Figure!17!L’).""
These" results" suggest" that" early" ectopic"wing" disc" activation" of" elav*enhancer" does" not"
imply" transcription"of" the"corresponding"gene,"at" least"as" judged"by" its"encoded"protein"
(Fig.!17!K/L’)."
"
8.1.2!Toll26! enhancer! (D42<Gal4)! is! transiently! activated! in!wing! imaginal! discs! during!
first!12h!after!egg<laying"
To"test"if"the"phenomenon"observed"with"the"elav"enhancer"is"general"to"other"enhancers,"
we" selected" the" line" D42/Gal4," which" corresponds" to" a" Toll86" gene" enhancer" (Sanyal,"
2009)," as" another" case" also" described" as" nervous" system" specific." Neurons" in" the" third"
instar"larval"brain"activated"D42"during"early"development"(Figure!R18!C)."Similar"to"elav,"
D42" is" also" activated" in"wing"disc" cells" during"early"development"but"not" at" third" instar"
larvae" (Figure! R18! H)," as" only" GFP/positive" cells" are" detected." In" addition," D42/Gal4"
domain"in"the"wing"disc" is"also"different"between"left"and"right"discs" in"the"same"animal"
(data"not"shown)."
Next,"to"determine"the"temporal"activation"of"the"D42"enhancer,"we"used"the"repressor,"
Gal80ts," and" analyzed" the" resulting" G/TRACE" pattern" for" D42" enhancer" (Fig! R18! A)." As"
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controls," we"maintained" the" larvae" at" 17°C" (negative" control," Figure! R18! D)" or" at" 29°C"
(positive" control,"Figure!R18!H)." The"negative" control" shows"no"G/TRACE" signal" and" the"
positive"control"yields"full"enhancer"expression"in"the"brain."We"set"five"time"points"(OFF,"
12hOFF," 24hOFF," 48hOFF" and" ON)" corresponding" to" the" hours" that" the" system" is" kept"
silenced"(Fig.!R18!A)."Our"results"show"that,"if"the"system"is"silenced"during"48h"(Fig.!R18!
E),"24h" (Fig.!R18!F)"or"12h" (Fig.!R18!G)"of" larval"development," the"ectopic"expression"of"
D42" does" not" occur" (Figure! R18! D/H," quantified" in" I)." These" data" suggest" that" D42"
activation"occurs"during"the"first"12"hours"of"larval"development,"mainly"(Fig.!R18)."
"
8.1.3!Toll26!gene!product!is!not!necessary!for!wing!disc!development"
To"resolve"if"Toll6"gene"expression"is"necessary"for"the"development"of"the"wing"disc,"we"
expressed"a"Toll6"specific"iRNA"under"the"control"of"D42/Gal4."Staining"with"anti/caspase"3"
and"anti/wingless"antibodies,"did"not"detect"any"apoptosis"or"wg"pattern"defect"and"the"
adult" wing"morphology" was" normal" (Figure! R19"A/H)." These" results" suggest" that," even"
though"the"Toll6"enhancer"D42"shows"activity"in"the"wing"disc"during"development,"Toll6*
gene" expression" is" not" switched" on" during" wing" development," at" least" to" the" point" of"
manifesting"a"visible"phenotype"in"disc"size,"shape,"wg"pattern"or"adult"wing"morphology."
To"further"determine"if"the"ectopic"enhancer"expression"implies"a"transient"expression"of"
another" gene" under" UAS" control," we" used" Basket* (Bsk)." This" gene" product" induces"
apoptosis"by"driving"a"core"component"of"the"JNK"pathway,"(Moreno"et"al.,"2002)."Driven"
under"D42/Gal4"we"stained"with"anti/caspase/3"and"with"anti/Wingless" to"evaluate"wing"
disc" development." The" early" activation" of" D42/Gal4/Toll86" lead" to" Bsk/dependent"
apoptosis," as" revealed" by" caspase/3" staining," to" abnormalities" in" the" Wg" pattern" and"
resulted"in"defective"adult"wings"(Fig!R19!E/I)."
Together," these" findings" indicate" that" two" classical" neuronal" enhancers," elav/Gal4" and"
D42/Gal4,"are"transiently"activated"in"wing"epithelial"cells"during"early"development."The"
expression"activation"of"the"corresponding"native"genes,"elav"and"Toll86"do"not"appear"to"
yield"detectable"proteins,"but"can"be"used"to"achieve"ectopic"gene"expression" (Fig.!R17,"
R18"and"R19)."
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Thus,"elav/Gal4"and"D42/Gal4"lines"can"be"used"as"genetic"tools"to"transiently"express"any"
given" gene" in" epithelial" cells" of" the" wing" disc" during" early" development." The" transient"
activation" period" of" the" enhancers" varies" with" each" enhancer" and" depends" on"
chromosomal"location"of"the"insertion."
"
8.2!Adult!wing!defects!in!Aβ42"flies!are!restored!by!PI3K!overexpression!!
Taking" advantage" of" the" transient" activation" of" elav/Gal4" and" D42/Gal4" enhancers" in"
epithelial"cells,"we"wondered"if"Aβ42"also"elicits"defects"in"tissue"growth"and"development"
in" the"wing" discs."We" tested" the" Aβ42" deleterious" effect"with" the" D42/Gal4" driver" and"
analyzed"adult"wings"morphology."
Adult"wings"of"Aβ42" flies"grown"at"29°C"presented"severe"abnormalities" (Fig.!R20)."PI3K"
flies"showed"no"defects"in"adult"wing,"and"only"5%"of"PI3K/Aβ42"flies"showed"noticeable"
defects"in"their"wings"(Fig.!R20)"
These"findings"confirmed"that"Aβ42"affects"non/neuronal"tissues,"and"further,"the"effects"
in"epithelial"cells"can"be"reduced"by"PI3K"overexpression.""
"
8.3!PI3K!overexpression!reduces!Aβ42<induced"apoptosis! in!epithelial!cells!of!the!wing!
disc"
Thanks"to"the"transient"activation"of"D42/Gal4" in"the"wing"disc,"we"confirmed"that"Aβ42"
could"degenerate"epithelial"cells" that" later"developed" into"malformed"adult"wings."Thus,"
we"wondered"if"these"effects"could"trigger"caspase/3"activation."
For"that,"we"stainned"discs"with"anti/caspase/3"antibody"using"the"engrailed/Gal4"driver,"a"
domain"that"occupies"the"posterior"compartment"of"the"wing"disc"(Fig.!R21!A/B’).""
We"observed"caspase/3"activation"upon"Aβ42"expression"in"third"instar"larvae"wing"discs"
(Fig.!R21!A,"A’)."PI3K/Aβ42"wing"disc" region"showed"reduced"caspase/3"activation"when"
compared"to"Aβ42,"although"some"caspase/3"positive"signal"was"still"detected"(Fig.!R21!B,"
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B’)." " The" control" region" (anterior" compartment" of" the" wing" disc)" showed" no" caspase/3"
activation"(Fig.!R21!A/B’)."
Knowing"that"PI3K"can"induce"proliferation,"we"further"looked"for"phosphorylated"histone/
3"(pH3)"signals"(Fig.!R21!C/D’)."Histone/3"becomes"phosphorylated"in"the"mitotic"processes"
during"chromatin"condensation"and"is"often"used"as"a"reporter"of"cell"proliferation"(Hans"
and"Dimitrov,"2001).""
Both,"Aβ42"(Fig.!R21!C,"C’)"and"PI3K/Aβ42"(Fig.!R21!D,"D’)"genotypes"showed"pH3"positive"
cells."Likewise,"control"areas"(anterior"compartment)"showed"pH3"signals"(Fig.!R21!C/D’)."
Thus,"no"alterations"in"normal"pH3"signal"were"found"due"to"the"overexpression"of"either"
Aβ42"or"PI3K"and"Aβ42"combination."
Taken"together,"these"observations"indicate"that"Aβ42"can"induce"caspase/3"activation"in"
epithelial" cells," and" that" this" activation" can" be" reduced" with" PI3K" overexpression." In"
addition,"neither"Aβ42"nor"PI3K/Aβ42"induce"proliferation"as"no"increment"in"pH3"positive"
cells"is"found"when"we"compare"to"control"areas"(Fig.!R21)."
"
8.4!PI3K!overexpression!restores!Wnt!signaling!impairment!caused!by!Aβ42!in!epithelial!
cells!of!the!wing!disc"
Several"Wnt"family"components"are"dysregulated"in"AD"(reviewed"in"Inestrosa"and"Varella/
Nallar,"2014)," and" some"of" these"elements"have"also"been" implicated" in" synaptogenesis"
(Franciscovich"et" al," 2008)."Being" the"wing"disc"of"Drosophila" a" very" suitable" system" for"
signaling"studies,"we"investigated"if"Aβ42"and"PI3K/Aβ42"could"affect"Wnt"signaling."
In" line"with"previous"experiments,"we" stained" third" instar" larval"wing"discs"with" specific"
anti/Wingless"and"anti/Armadillo/β/catenin"antibodies"(Fig.!R22)."
We"observed"alterations"of"the"Wingless"pattern"in"Aβ42"area"(P"compartment)"(Fig.!R22!
A,"A’)"when"compared"to"the"control"area"(A"compartment)."Moreover,"the"armadillo/β/
catenin"signal"is"reduced"in"the"Aβ42"area"(Fig.!R22!C,C’)."
PI3K"overexpression," in"combination"with"Aβ42,"showed"normal"Wingless"pattern"across"
the" wing" disc," both" in" PI3K/Aβ42" and" control" areas" (Fig.! R22! B,B’)." Furthermore,"
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armadillo/β/catenin" signal" showed" homogeneous" levels" in" control" and" PI3K/Aβ42" areas"
(Fig.!R22!D,D’)."
Together,"these"data"indicate"that"Aβ42"misregulates"Wnt"signaling"in"epithelial"cells,"and"
that"these"alterations"are"restored"with"PI3K"co/expression"(Fig.!R22)."
" "
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1. SYNAPTOGENESIS!IN!Aβ42!NEURODEGENERATION!
2. NOVEL!EFFECT!OF!PI3K!IN!Aβ42!AGGREGATION!
3. Aβ42!EFFECTS!IN!NON<NEURONAL!CELLS.!NEW!NON<SYNAPTIC!ACTIONS!OF!PI3K!
OVER!Aβ42!CYTOTOXICITY.!
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Knowing" that" in" AD" synapse" loss" is" one" of" the" first" steps" in" the" progression" of" the"
neurodegenerative" process," and" that" previous" studies" have" demonstrated" the" age"
independent"synaptogenic"actions"of"PI3K" in" in*vitro"and" in*vivo" studies" (Martin/Pena"et"
al.," 2006," Acebes" et" al.," 2011," Cuesto" et" al.," 2011)," we" studied" the" potential" beneficial"
effects"of"PI3K"overexpression"in"an"adult/onset"model"of"AD"in"Drosophila."
Taking" advantage" of" the" binary" Gal4/UAS" expression" system," in" combination" with" the"
Gal80ts"construct,"that"allows"temporal"control"of"the"Gal4"protein"synthesis"(see"Chapter"
3)," human" Aβ42" peptide" was" expressed" in" the" nervous" system" of" adult" flies." The"
importance"of"this"experimental"design"rise"from"the"fact"that"Aβ42"expression"is"inhibited"
during" the" developmental" stages" of" Drosophila" (embryo," larva" and" pupa)" and" is" only"
activated"when" flies" reach"adulthood"and"eclosionate" from" their"puparium."Other" study"
has" used" a" similar" strategy" with" the" GeneSwitch" system" (Sofola" et" al.," 2010)," which"
controls" Gal4/UAS" system" activation" by"mifepristone" (RU486)" treatment." However," the"
majority"of"AD"models,"in"Drosophila"and"other"organisms,"follow"constitutive"expression"
of" the" Aβ" peptide," APP," PS1," tau," in" their"mutated" or"wild" type" forms" (Ashe" and" Zahs,"
2010," Wisniewski" and" Sigurdsson," 2010," De" Felice" and"Munoz," 2016)." Aβ42" formation,"
although" achieved" at" all"moments" in" life," is" only" known" to" exhibit" toxic" effects"when" it"
exponentially" increases" due" to" rapid" production" or" insufficient" degradation." Aβ42"
accumulation"has"only"been"detected"in"elderly"individuals,"and"never"at"younger"ages."For"
that,"the"use"of"Gal80ts/Gal4/UAS"system"in"Drosophila"can"be"very"useful"in"modeling"AD"
neurodegenerative"progression."
"
1.!Synaptogenesis!in!Aβ42!Neurodegeneration*
In"this"work,"we"show"in*vivo"evidences"of"the"synaptogenic"effect"of"PI3K"activation"in"a"
pathological" context" were" synapses" are" toxically" affected" by" Aβ42." Morphological"
observation" of" active" zones" (Bruchpilot" puncta)" across" genotypes" and" time/points"
demonstrated"that"Aβ42"expression"at"15"days"elicits"ultraestructural"misorganization"of"
AZs," and" that" PI3K/Aβ42" combination" reverted" this" defect." Presynaptic" affectation" by"
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Aβ42" has" not" been" as" deeply" studied" as" the" postsynaptic" effects," where" Aβ42" directly"
interacts" with" NMDA," mGluR5," PrP," p75" and" other" receptors" (Benilova" et" al.," 2012)"
impairing"LTP"and"inducing"LTD"enhancement"(see"Chapter"1"“Introduction”)."Thus,"direct"
effects" in" the" presynaptic" region," or" in" postsynaptic" densities," that" could" therefore"
indirectly" affect" AZs," could" both" cause" the" changes" shown" in" active" zone" surface." A"
previous"study"in"our"lab"has"demonstrated"that"presynaptic"PI3K"activation"promotes"the"
assembly"of"glutamate"receptors"(Jordan/Alvarez"et"al.,"2012)."These"findings"mean"that,"
although"we"are"not"sure"if"Aβ42"is"affecting"the"presynaptic"or"the"postsynaptic"region"in"
the"first"place,"PI3K"activation"can"elicit"changes"in"both"synapse"sides."Therefore,"a"direct"
interaction"of"PI3K"and"Aβ42"is"possible."
Our" results" could" be" a" consequence" of" an" indirect" interaction" between" PI3K" and" Aβ42,"
where" the" synaptogenic" actions" of" PI3K" would" be" fighting" against" the" synaptic" loss"
triggered"by"Aβ42;"nevertheless"they"could"also"be"caused"by"a"direct"interaction,"as"has"
been"suggested"by"other"groups."PTEN"is"a"lipid"phosphatase"that"inhibits"PI3K"activation"
(Maehama"and"Dixon,"1998),"and"it"has"been"found"to"directly"mediate"Aβ42"synaptic"and"
cognitive"impairments"(Knafo"et"al.,"2016)."PTEN"can"regulate"LTD"(Jurado"et"al.,"2010)"and"
when" studied" in" AD" models," PTEN" can" be" targeted" by" Aβ42" to" synaptic" spines."
Furthermore," pharmacological" administration" of" a" PTEN"membrane/permeable" peptide,"
unable" to" interact" with" Aβ42" through" PDZ" domains," rescues" the" synaptic" deterioration"
(Knafo" et" al.," 2016)." Morevover" GSK3/β" (PI3K/Akt" pathway" inhibitor)" is" known" to" elicit"
anti/synaptogenic"actions"in"Drosophila"and"mice"(Martin/Pena"et"al.,"2006,"Cuesto"et"al.,"
2015),"and"participates"in"LTP"and"long/term"memory"(Hooper"et"al.,"2008)."Likewise,"Jun"
kinase/AP/1"and"Wnt"signaling"are"also"members"of"the"synaptogenic"pathway,"as"they"are"
regulated"by"GSK3"(Franciscovich"et"al.,"2008)."In"AD,"GSK3"is"known"to"phosphorylate"tau"
and" therefore" regulate"microtubule" dynamics" (Llorens/Martin" et" al.," 2014)" therefore," it"
has"become"one"of"the"most"tested"therapeutic"targets"in"AD."
PIP3,"synthetized"by"PI3K,"regulates"PSD/95"accumulation"and"synaptic"AMPA"receptors"in"
spines," affecting" synaptic" strength" (Arendt" et" al.," 2010)." In" this" line," cyclic" adenosine"
monophosphate" (cAMP)" response" element/binding" protein" (CREB)" has" been" showed" to"
play" important" roles" in" memory" formation" and" consolidation" (Levenson" et" al.," 2004,"
Korzus"et"al.,"2004)."This"cAMP/PKA/CREB"pathway"that"regulates"histone"acetylation"and"
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thus"gene"transcription,"has"also"been"studied" in"Alzheimer’s"models" (Chen"et"al.,"2012)"
and"is"being"used"as"a"target"for"potential"therapeutic"treatments"(Teich"et"al.,"2015)."
Our"data"suggest"that"neither"Aβ42"nor"PI3K"promote"mRNA"changes" in"AZ"components"
(bruchpilot," liprin" and" synaptobrevin)," although" transcriptional" regulation" cannot" be"
excluded" from" the" possible" mechanisms" associated" to" Aβ42" and" PI3K." These"
transcriptional"alterations,"or"even"post/transcriptional"regulations"could"modify"synaptic"
proteins" availability," turnover," degradation" and/or" trafficking," leading" to" the" synaptic"
changes"described"in"our"results."
Our"microtubule"dynamics"data"showed"that"Aβ42"larvae"had"a"reduced"number"of"comet"
density."This"affectation"was"reverted" in"PI3K/Aβ42,"suggesting"that"PI3K"overexpression"
can"restore"Aβ42"induced"microtubule"alterations."
Defects"in"microtubule"dynamics"are"known"to"elicit"trafficking"dysfunctions."Also,"Brp"and"
other" components" of" the" AZs" and" PSDs" need" to" be" transported" via" microtubules," and"
changes"in"tubulin"cytoskeleton"stability"can"generate"problems"not"only"in"the"formation"
of"new"AZs"or"PSDs"structures,"but"also"in"synaptic"protein"turnover."Our"data"confirm"that"
Aβ42"affects"microtubule"dynamics,"and"more"specifically"demonstrate"that"Aβ42"reduces"
the" number" of" growing" events," leading" to" a" less" dynamic," and" thus" ineffective,"
cytoskeleton."This"would"suggest"that"Brp"transport"to"the"AZ"could"be"affected"and"might"
explain"the"reduced"synaptic"area" in"adult"NMJs."More" importantly,"PI3K"overexpression"
led" to" a" total" recovery" in" microtubule" dynamics," allowing" the" normal" transportation"
and/or"turnover"of"synaptic"proteins." "However,"our"results"do"not"demonstrate"a"direct"
interaction"between"Aβ42"or"PI3K"with"EB1.""
Knowing"that"PI3K"alone"promotes"an"increase"in"synapse"number,"which"was"confirmed"
in"this"work,"our"data"suggest"that"this"could"also"be"causing"lifespan"increase."PI3K"is"at"
the"crossroads"of"different"signaling"pathways"that"elicit"a"wide"range"of"cellular"processes"
such"as:"cell"growth,"proliferation,"differentiation,"cell"survival"and"intracellular"trafficking"
(Acebes" and" Morales," 2012)." Thus," the" demonstrated" synaptogenic" actions" that"
counteract"Aβ42"neurotoxicity"could" trigger" the"activation"of"PI3K/Akt"classical"effectors"
and"its"cellular"consequent"cellular"responses."
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In" this" study," we" further" tested" the" effect" of" a" classical" PI3K" effector,"mTOR." Although"
mTOR"in"implicated"in"memory,"previous"studies"in"our"lab"have"demonstrated"that"mTOR"
overexpression"does"not"generate"new"synapses,"therefore"is"not"considered"to"be"a"part"
of"the"synaptogenic"pathway.""
Synapse" quantification," locomotion" assay" and" lifespan" performance" of" flies" expressing"
Aβ42" together" with" mTOR," showed" that" this" non/synaptogenic" tool" failed" to" restore"
neurodegeneration." This" means" that" PI3K" neuroprotective" effect" in" synapses" does" not"
follow"the"canonical"signaling"path."
On"the"other"hand,"to"verify" if"synaptogenesis"was"the"process"preventing"Aβ42"toxicity,"
we"took"advantage"of"the"knockdown"of"Medea,"a"genetic"tool"that"had"been"previously"
demonstrated"to"exert"novel"synaptogenic"actions"(McCabe"et"al.,"2003)."Further"studies"
in" our" lab" have" confirmed" that" Medea" participates" with" its" molecular" partner," Mad"
(mother" against" decapentaplegic)" in" the" same" synaptic" signaling" cascade" that" PI3K,"
although"they"have"opposing"roles.""Medea"is"considered"an"antisynaptogenic"protein,"and"
thus,"we"decided"to"test" its"downexpression," to" increase"synapse"number"and"study"the"
effects" in" our" Aβ42" model." Interestingly," Medea" downregulation" resulted" in" synapse"
restoration" and" total" prevention" of" Aβ42" induced" effects" in" locomotion" activity" and"
lifespan."Taking"all"these"data"together,"synaptogenesis"has"been"proved"to"prevent"Aβ42"
neurotoxic"effects"and"to"rescue"functional"defects"associated"to"neurodegeneration."
mTOR"and"Medea"experiments"help"us"understand"the"mechanism"by"which"PI3K"serves"
as"a"protective"protein"from"Aβ42"neurotoxicity."Nonetheless,"it"is"important"to"remember"
that"PI3K"can"mediate"many"other" intracellular"processes."Hence," it" is"possible" that"pro/
survival"signaling"could"also"cause"the"beneficial"actions"that"PI3K"exhibits" in" lifespan." In"
the" future," further" studies"will" address" this" issue" and" decipher"whether" synaptogenesis"
and"survival"cues"can"be"separated."
PI3K/Akt/mTOR"signaling" is"conserved"across"phyla" (Ruggero"and"Sonenberg,"2005),"and"
so" seem" to" be" PI3K" synaptogenic" actions," since" studies" in" Drosophila,"mice" and" human"
cells"have"corroborated"this"fact"(Cuesto"et"al.,"2011,"Jordan/Alvarez"et"al.,"2012,"Enriquez/
Barreto"et"al.,"2014)."Moreover,"in"this"work"we"have"evaluated"the"preventive"actions"of"
PI3K" in" Drosophila" and" in" human" neuroblastoma" cells," to" Aβ42mediated"
! 69"
neurodegeneration."Our"findings"demonstrated"that"PI3K"activation"can"be"proposed"as"a"
target"to"prevent"AD"progression,"and"that"PTD4/PI3KAc"peptide"is"a"powerful"tool"in"this"
matter.""
Besides,"Medea"downexpression"could"also"become"a"potential"target"for"AD"therapies,"as"
it" restores" synapses" locomotion" and" lifespan" of" Aβ42" affected" flies." In" addition,"Medea"
downregulation"has"shown"to"block"BMP"signaling"(ref)"which"is"in"turn"altered"in"AD"(ref)."
On"the"other"hand,"mTOR"appears"to"enhance"the"neurotoxic"effects"of"Aβ42"in"lifespan,"
and" when" overexpressed" alone," showed" similar" reduction" in" synapses" than" Aβ42" flies."
These" findings" go" in" the" same" line"of" published"data" from"other" labs,"where"mTOR"has"
been" found" to" participate" in" memory" formation" and" consolidation," and" has" also" been"
described"to"be"a"target"of"Aβ42."Thus,"mTOR"inhibition"appears"as"a"potential"target"for"
further"AD"studies."
"
2.!Novel!effect!of!PI3K!in!Aβ42!aggregation!
In"this"work,"we"show"evidences"for"a"new"role"of"PI3K"in"Aβ42"accumulation."Our"in*vivo"
and" in*vitro"results"have"demonstrated"the"ability"of"PI3K"to"induce"faster"aggregation"of"
Aβ42" assemblies," leading" to" a"more" insoluble" aggregative" pattern" change." Interestingly,"
this" increase" in" insoluble" Aβ42" species" correlates" with" better" lifespan," locomotor" and"
synaptic"data,"suggesting"that"PI3K"induced"change"in"aggregation"might"be"beneficial"by"
for"AD."
Previous" studies" consider" fibrillar" insoluble" deposits" of" Aβ42" rather" benign" species"
(DaRocha/Souto"et"al.,"2011,"Moreth"et"al.,"2013)," in"contrast" to"soluble"and"more" toxic"
Aβ42"oligomers."Although"larger"and"more"insoluble"accumulations"could"be"very"difficult"
to" degrade" by" the" three" known" Aβ42" degrading" enzymes:" neprilysin," insulin" degrading"
enzyme"or"endothelium"converting"enzyme"(Turner"et"al.,"2004)"they"have"been"proposed"
to"serve"as"a"sink"for"oligomers.""
Many" efforts" are" being" directed" to" decipher" the" structural" changes" of" Aβ42" leading" to"
different"aggregation"patterns"that"could"therefore"change"its"accumulation,"toxicity"and"
70"
in"the"end,"AD"progression."
Aβ"monomers"are"mainly"α/helical"structures"and/or"unordered"structures"that"can"suffer"
conformational" changes," that" in" turn," promote" hemophilic" interactions" and" eventually"
lead" to" Aβ" oligomer" formation." Due" to" these" conformational" changes," the" resulting"
polymers"become"rich"in"β/sheet"structures.""
Besides," post/translationally" modified" Aβ" species" have" been" identified" (Kummer" and"
Heneka," 2014," Kuo" et" al.," 2001)" including" truncation" (Hartig" et" al.," 2010)," racemization"
(Murakami" et" al.," 2008)," isomerization" (Shimizu"et" al.," 2000)," pyroglutamination" (Kuo"et"
al.," 1997)," metal/induced" oxidation" (Dong" and" Bai," 2003)" and" phosphorylation" (Milton,"
2001,"Kumar"et"al.,"2011)."
Phosphorylation" in"particular"can"be"potentially"achieved"at"3"different"sites" in"the"Aβ42"
aminoacid" sequence:" serines" at" position" 8th" and" 26th," and" tyrosine" at" position" 10th." In"
addition,"Aβ"has"been"previously" found" to"undergo"phosphorylation"by"protein"kinase"A"
and"cyclin/dependent"kinase"(cdc)"2" in*vitro" (Milton,"2001)."Specially,"phosphorylation"at"
serine/8" by" protein" kinase" A" was" observed" in" free" extracellular" Aβ" rather" than" in" its"
precursors" (APP" or" β/CTF)" and" promoted" the" formation" of" toxic" aggregates." Also,"
phosphorylated"deposits"from"APP"transgenic"mice"were"found"concentrated"in"the"center"
of" the"plaque" (Kumar"et"al.,"2011)."Phosphorylation" in" this"particular" residue" (ser/8)"has"
been" documented" to" induce" Aβ" resistance" to" degradation" by" insulin" degrading" enzyme"
(Kumar"et"al.,"2012)."
Another" study" described" cdc" 2" phosphorylation" at" residue" serine/26" in" an" in* vitro"
approach" (Milton," 2001)." In" this" case," no" detailed" analysis" was" performed" about" the"
potential" changes" in" aggregation," although" cell" treatment" with" olomoucine" prevented"
cytotoxicity"and"Aβ"phosphorylation,"suggesting"that"aggregative"forms"favored"by"ser/26"
phosphorylation" enhance" Aβ" toxicity." " In" contrast," our" data" suggest" that" PI3K/induced"
phosphorylation" in" ser/26" ameliorates" Aβ" neurodegenerative" effects" and" promotes"
insoluble"Aβ"assemblies"formation."
Recent" in* vitro" analysis" of" Aβ40" phosphorylated" at" ser/26" has" described" that" this"
modification" impairs" fibrillization" while" stabilizing" monomer" and" non/toxic" soluble"
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aggregates."Computational"studies"predicted"that"a"phosphate/group"at"residue"26"could"
rigidify" the" region" and" interfere" with" a" fibril/specific" salt/bridge" (Rezaei/Ghaleh" et" al.,"
2014)."
A" specific" region" in" the" Aβ" sequence" comprising" residues" 25/29" generates" a" bend/like"
structure" that" juxtaposes" the" hydrophobic" faces" of" the" two" cross/β" units." This" bend"
formation"is"important"for"the"pathogenic"aggregation"of"Aβ"(Murray"et"al.,"2009,"Fawzi"et"
al.," 2008)." Other" studies" have" further" emphasized" the" importance" of" the" ‘Glycine" 25" /"
Serine" 26’" dipeptide" in" Aβ42" monomer" structure" organization" by" finding" changes" in"
aggregative" properties" upon" biochemical" modifications" in" these" two" residues"
(Roychaudhuri"et"al.,"2014)."They"have"proposed"a"potential"use"of"drugs"that"could"alter"
the" interactions" of" this" dipeptide" with" neighboring" side/chain" atoms" or" with" the" core"
sequence"of"the"peptide.""
Moreover," specific" mutations" in" APP," specifically" in" this" region," are" known" to" induce"
aggregation"propensity,"such"us"Arctic"(E22G),"Italian"(E22K),"Dutch"(E22Q),"Osaka"(E22Δ)"
and"Iowa"(D23N)."These"variants"can"cause"early"onset"familial"AD"(Benilova"et"al.,"2012)."
Thus,"given"the"biochemical"and"biophysical"properties"of"Aβ"peptide,"more"studies"should"
explore" new" therapies" triggering" specific" residue" modifications" like" phosphorylation" or"
dephosphorylation" which," in" turn," could" change" Aβ" aggregation" patterns" to" less" toxic"
assemblies." These" strategies" combined" with" drugs" to" enhance" Aβ" clearance" and"
degradation"would"potentially"be"very"beneficial"for"AD"patients."
Protein"kinases"(PKs)"in"general"play"important"roles"in"cell"cycle"control,"gene"regulation"
and"learning"and"memory"(Giese"and"Mizuno,"2013,"Johnson"and"Barford,"1993)"and"they"
can" assert" their" phosphorylation" activities" inside" of" the" cell" or" even" outside" of" the" cell,"
where" they" can" phosphorylate" cell/surface" proteins" or" soluble" extracellular" substrates"
(Redegeld"et"al.,"1999,"Shaltiel"et"al.,"1993,"Walter"et"al.,"1994)."These"Ecto/PKs"and"Exo/
PKs,"that"catalyze"their"activities"at"the"external"cell"surface"or"in"the"extracellular"media"
respectively," can" use" extracellular" ATP," which" is" present" in" the" brain" at" nanomolar"
concentrations" and" can" also" increase" locally" upon" certain" stimuli" (Gourine" et" al.," 2007,"
Melani"et"al.,"2005,"el/Moatassim"et"al.,"1992)."
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Thus," extracellular" phosphorylation" of" Aβ" is" biochemically" possible" by" protein" kinases."
Although" in" depth" studies" are" needed" in" order" to" completely" understand" the" structural"
changes"that"Aβ"phosphorylation"could"have"in"amyloid"aggregation"and"AD"progression."
"
3.! Aβ42! effects! in! non<neuronal! cells.! New! non<synaptogenic! actions! of! PI3K! in! Aβ!
toxicity!
Almost" thirty" years" ago," expression"of"APP" in" non/neuronal" cells"was" first" reported" and"
short" after," secretion" of" its" putative" Aβ" peptides"was" also" described" (Card" et" al.," 1988,"
Busciglio"et" al.," 1993)." Even" so,"until" very" recently," it"was"widely"accepted" that"neurons"
were" the" only" cells" producing" the" majority" of" Aβ" in" an" activity/dependent" manner"
(Kamenetz"et"al.,"2003)."Nowadays,"several"studies"have"demonstrated"that"also"glial"cells:"
astrocytes," oligodendrocytes" and" microglia" play" important" roles" in" AD" pathology" (De"
Strooper" and" Karran," 2016)." In" this" work," we" did" not" evaluated" the" effects" PI3K" in" Aβ"
induced"expression"in"glial"cells,"since"PI3K"activation"has"already"been"studied"in"glial"cells"
in"Drosophila"and"it" is"known"to"induce"proliferation,"for"which"is"being"used"as"a"model"
for"glioblastoma"(Read"et"al,"2009).""
AD" patients’" causes" of" death" are" mostly" attributed" to" bronchopneumonia" and"
cardiovascular"disease"(Brunnstrom"and"Englund,"2009,"Attems"et"al.,"2005)."Deleterious"
effects"in"non/neuronal"tissues"could"contribute"to"explain"the"cause"of"the"eventual"death"
of"the"patient.""
To"evaluate"the"toxic"effect"of"Aβ42"in"non/neuronal"tissues,"we"evaluated"the"affectation"
in"neurosecretory"cells"and"epithelial"cells"of"the"wing"disc"of"the"β/amyloid"Expression"of"
Aβ42" in" leucokinergic" cells" lead" to" inflated" abdomens," and" epithelial" expression" of" Aβ"
resulted" in" caspase/3" activation," as" well" as" Wnt" signaling" misregulation." Although" it" is"
thought"that"Aβ"affects"cells"differentially," it" is"not"well"understood"what"are"the"factors"
leading"this"cell" specificity."Our"data"suggest" that"even" if" the"mechanistic" features"of"Aβ"
toxicity" could" be" different," other" types" of" cells" out" of" the" nervous" system" are" also"
susceptible."
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We"have"observed"changes"in"Wnt"signaling"and"apoptosis"activation"upon"Aβ"expression,"
two" mechanisms" also" involved" in" Aβ" degeneration" in" neurons." Interestingly," PI3K"
activation" restored"also"Aβ" toxicity" in"both" leucokinergic" cells"and"epithelial" cells."Taken"
together,"these"observations"indicate"that"PI3K"is"able"to"counteract"Aβ"toxic"effects"not"
only"in"neurons,"but"also"in"neurosecretory"and"epitheial"cells,"although"more"studies"are"
needed"to"further"analyze"the"novel"non/synaptogenic"mechanisms"of"PI3K"activation"as"a"
preventive"agent"against"Aβ"toxicity."
4.!Perspectives!
Taking" together" the" data" presented" in" this" thesis," new" questions" arise" in" order" to" seek"
more"detailed"understanding"of" the"PI3K"actions" in"β/amyloid"neurodegeneration," since"
activation"of"Phosphoinositide/3"kinase"has"shown"to"induce"synaptogenic"protection"and"
aggregative"effects,"but"we"ask"if"both"outcomes"are"related,"being"one"the"consequence"
of" the"other,"or" if" PI3K" synaptogenic" and"aggregation"effects" are" independent."Knowing"
that" other" synaptogenic" strategies," like" Medea" down/expression," also" elicit" Aβ42"
protective" effects," we" wonder" if" in" this" scenario" Aβ42" aggregative" properties" are" also"
affected,"and"then,"what"could"be"triggering"the"aggregation"change?""
Interestingly,"although"PI3K"can" revert" the" loss"of" synapses" to"normal"control"values," its"
actions"are"not" sufficient" to"produce" total" recovery" in" locomotion"and" lifespan."Another"
open" question" arises" asking"what" other" negative" effects" of" Aβ42," if" any," are" not" being"
restored" by" PI3K?" In" the" case" of" Medea" knockdown" experiments," synapses" were" also"
reverted"to"control" levels,"and" locomotion"and"survival"Aβ"effects"are" totally"prevented."
Thus,"is"Medea"downregulation"triggering"better"functional"effects"in"synapses"that"those"
triggered" by" PI3K?" or" is" Medea" downregulation" mediating" other" synaptic/independent"
effects"that"contribute"to"Aβ42"protection?"
Newly" described"deleterious" effects" of"Aβ42" in" neurosecretory" cells" and" epithelial" cells,"
two" non/synaptic" environments," bring" numerous" questions:" Does" Aβ42" affect" epithelial"
and"neurosecretory"cells"in"AD"patients?"Are"those"effects"triggering"the"same"intracellular"
effectors?" Is" Aβ42" affecting" other" cell/to/cell" communication" structures" in" these" non/
synaptogenic" contexts?" Our" data" also" suggest" that" Drosophila" leucokinergic" cells" and"
epithelial"cells"can"be"used"to"further"study"Aβ42"effects,"as"especially"wing"disc"cells"have"
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been" long"studied"and"characterized,"and"a"wide"variety"of"genetic" tools"can"be"used"to"
address"new"questions"Aβ42"pathology"in"this"tissue."
Finally," PI3K" actions" in" a" synaptotoxic" scenario" could" also" be" studied" in" other"
neurodegenerative" models" like" Parkinson" disease," amyotrophic" lateral" sclerosis,"
Huntington"disease"or"frontotemporal"dementia."Moreover,"since"many"of"these"diseases"
develop" extracellular" and/or" intracellular" protein" aggregates," PI3K" actions" could" also" be"
studied"in"these"models"to"evaluate"if"it"could"mediate"changes"in"aggregation"propensity"
in"proteins"other"that"Aβ"peptide."
"
"
 !
"
"
" "
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CONCLUSIONS"
"
1. PI3K" overexpression" prevents" Aβ42/induced" synaptic" loss" in" an" age/independent"
manner."
2. Synaptic" protection" by" PI3K" overexpression" restores" microtubule" dynamics;"
however," it" does" not" affect" transcriptional" regulation" of" the" synaptic" proteins"
bruchpilot,"liprin"or"synaptobrevin."
3. PI3K" synaptogenic" actions" delay" the"Aβ42/induced" locomotion" degeneration" and"
lifespan."
4. "PI3K" activation" can" also" elicit" survival" recovery" in" human" neurons" treated" with"
Aβ42"oligomers."
5. Medea" down/expression," but" not" canonical" PI3K" effectors" like" mTOR," prevents"
Aβ42" mediated" synaptic" degeneration" and" recovers" the" β/amyloid" deleterious"
effects."
6. PI3K" overexpression" causes" changes" in" Aβ" aggregation" to" a"more" insoluble" non/
toxic"pattern."
7. PI3K" effect" in" Aβ42" aggregation" is" reproduced" in" in* vitro" studies" with" human"
neurons,"where"PI3K"can"promote"Aβ42"aggregation"outside"of"the"cell."
8. PI3K" overexpression" induces" the" phosphorylation" of" Aβ42" in" residue" Serine" 26"
which"is"critical"for"Aβ42"aggregation."
9. Aβ42"is"also"toxic" in"non/neuronal"environments,"where"PI3K"overexpression"also"
prevents"Aβ"toxicity."
10. Classical"neural"enhancers"show"transient"ectopic"activity"in"non/neuronal"tissues."
" "
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CONCLUSIONS"(in"Spanish)"
"
1. La" sobre/expresión" de" PI3K" previene" la" pérdida" sináptica" inducida" por" Aβ42" de"
manera"independiente"a"la"edad."
"
2. La" protección" sináptica" producida" por" la" sobre/expresión" de" PI3K" restaura" la"
dinámica" de" los" microtúbulos;" sin" embargo," no" afecta" a" la" regulación"
transcripcional"de"las"proteínas"sinápticas"Bruchpilot,"Liprina"o"Sinaptobrevina.""
"
3. La"acción"sinaptogénica"de"PI3K"retrasa"los"defectos"degenerativos"de"Aβ42"en"la"
actividad"locomotora"y"en"la"esperanza"de"vida."
"
4. La" activación" de" PI3K" produce" la" recuperación" de" la" supervivencia" en" neuronas"
humanas"tratadas"con"oligómeros"de"Aβ42."
"
5. La" bajada" de" expresión" de"Medea," pero" no" la" sobre/expresión" de" los" efectores"
canónicos"de"PI3K,"como"mTOR,"previene" la"degeneración"sináptica"mediada"por"
Aβ42"y"recupera"los"efectos"deletéreos"de"β/amiloide."
"
6. La" sobre/expresión" de" PI3K" provoca" cambios" en" la" agregación" de" Aβ" hacia" un"
patrón"más"insoluble"y"por"tanto,"considerado"menos"tóxico."
"
7. Los"efectos"de"PI3K"en"la"agregación"de"Aβ42"también"se"reproducen"en"estudios"
in*vitro"con"neuronas"humanas,"donde"PI3K"puede"promover"la"agregación"de"Aβ"
fuera"de"la"célula."
"
8. La"sobre/expresión"de"PI3K"induce"la"fosforilación"de"Aβ42"en"el"residuo"Serina/26,"
que"es"crítico"para"la"agregación"del"péptido"amiloide."
"
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9. Aβ42" causa" efectos" deletéreos" en" ambientes" no/neuronales," donde" la" sobre/
expresión"de"PI3K"también"es"capaz"de"prevenir"su"toxicidad."
"
10. Enhancers" neuronales" clásicos" muestran" una" actividad" ectópica" transitoria" en"
tejidos"no/neuronales,"como"el"epitelio"del"disco"de"ala"de"Drosophila."
"
" "
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FIGURE"LEGENDS"
!
Fig.!I1!Hypothetical!model!for!the!temporal!progression!of!AD!markers.!Schematic"graph"
representing"the"abnormal"progression"of"AD"biomarkers."Biomarkers"start"to"abnormally"
change"before"they"reach"the"detection"threshold"(black"horizontal"line),"as"it" is"denoted"
by" the"gray"area" in" the"graph."Aβ" levels" are" the" first"measures" to"be"detected" (red"and"
purple"arrows),"followed"by"tau"(light"blue"arrow),"FDG"PET"and"MRI"(dark"blue"arrow)"and"
cognitive" impairment" (green" arrow)." Light" green" filled" area" represents" the" range" of"
cognitive"responses,"which"depends"on"each"individual’s"risk"profile."Extracted"from"Hardy"
and"Selkoe"2016."
Fig.!I2!Sequence!of!events!proposed!in!Aβ!cascade!for!AD!pathology.!"Both"inherited"and"
not/inherited" forms" of" AD" converge" in" the" accumulation" and" oligomerization" of" Aβ"
species," which" induce" the" progression" of" the" rest" of" events" to" eventually" result" the"
cognitive" and"memory" impairment" that" AD" patients"manifest." This" hypothesis" proposes"
that"Aβ"assemblies"are"the"leading"cause"of"AD,"as"they"directly"induce"early"synaptic"loss."
(Adapted"from"Hardy"and"Selkoe"2002;"Hardy"and"Selkoe"2016)"
Fig.!I3!APP!proteolytic!processing.!Schematic"cartoon"representing!the"amyloidogenic"and"
non/amyloidogenic" processing" that" the" full/length" APP" can" suffer." In" the" amyloidogenic"
pathway" (right)" β" and" γ" secretases" sequentially" cut" APP" generating" the" resulting" Aβ"
peptide" (orange" fragment)" and" the" AICD" fragment" (purple)." In" the" non/amyloidogenic"
pathway"(left)"a"different"cleavage"is"accomplished"by"the"α/secretase"first,"and"thus,"the"
resulting" fragment," after" being" processed" by" the" γ/secretase," different" fragments" are"
released,"p3"(orange)"and"AICD"(purple)."(Adapted"from"Nicolas"and"Hassan"2014)."
Fig.! I4! Aβ! aggregates.!Schematic" cartoon" representing" the" different" Aβ" assemblies" that"
can"be"generated"upon"β/amyloid"aggregation."APP" full/length"protein" is" represented" in"
purple,"with"the"Aβ"fragment"in"orange."Arrows"indicate"the"cleavage"elicited"by"β"and"γ"
secretases."The"spectrum"of"Aβ"species"range"from"soluble"monomers"to"insoluble"fibrils"
and" are" known" to" vary" from" less" toxic" assemblies" (green)" to" more" toxic" aggregates"
(orange)."
Fig.! I5! Aβ! effects! in! synaptic! transmission.! Schematic" representation" summarizing" the"
hypothetical" sequential" effects" of" Aβ" in" presynaptic" and" postsynaptic" regulation." " Aβ"
abnormally" low"and"high" levels" impair"synaptic"activity,"but" intermediate" levels"enhance"
synaptic" activity" (a)." In" particular," intermediate" Aβ" levels" affect" presynaptic" and" post/
synaptic"terminals" (b),"but"high"Aβ" levels"regulate"only"postsynaptic"functions"(c)." (Palop"
and"Mucke"2010)."
Fig.! I6! APP! structure! and! domains! across! species.! Schematic" representation" of" APP"
domain"structure"in"Homo*sapiens,"Mus*musculus,"Dario*rerio,"Caenorhabditis*elegans*and"
Drosophila* melanogaster." The" following" domains" are" represented:" Heparin/binding"
domain" (HBD)," copper/binding" domain" (CuBD)," acidic" domain" (Ac)," Kunitz" protease"
inhibitor"domain"(KPI),"E2"domain"(E2)"containing"a"Zinc"binding"site"in"APLP1"(Mayer"et"al,"
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2014)"and"known"to"bind"heparin/sulphate"proteoglycans,"Aβ"sequence"(Aβ)"and"a"specific"
domain"conserved"across"species"that"serves"as"a"signal"for"clathrin/mediated"endocytosis"
and"binding"site"for"cytosolic"adaptor"proteins"(YENPTY)."
Fig.! I7! Location! and! structure! of* Drosophila! neuromuscular! active! zone.! Schematic"
cartoon" representing" the" pre/synaptic" and" post/synaptic" sides" of" a" synapse," and" in"
particular,"active" zones"ultrastructure"as" revealed"by"high/resolution"LM" (Liu"et"al"2011)"
(adapted"from"Südhof"2012)."
"
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Fig.!M1!Gal4/UAS!system!for!directed!gene!expression.!Schematic"representation"of"the"
Gal4/UA"system"(St"Johnston"2002)."
Fig.!M2!Gal80TS!repressor!system.!Scheme"representing"the"termosensitive"Gal4"repressor"
system"Gal80TS"system"(McGuire"et"al"2003)."
Fig.! M3! G<TRACE! analysis! system.! ! Schematic" cartoon" representing" the" molecular"
mechanism"of"the"G/TRACE"(Gal4"Technique"for"Real/time"And"Clonal"Expression)"(Evans"
et"al,"2009)."
!
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Fig.! R1! PI3K! activation! prevents! Aβ42! induced! synapse! loss.! (A<D’’)! Representative"
confocal" image" examples" of" Bruchpilot" immunostainings" visualizing" adult" VLM" NMJs"
expressing" UAS/lacZ" (control)," UAS/PI3Kcaax," UAS/Aβ42(2x)," and" UAS/PI3KCAAX/UAS/
Aβ42(2x)"constructs"at"7"(A/D),"15"(A’/D’)"and"25"days"of"expression"(A’’/D’’)"with"elavc155/
Gal4/TubGal80TS." (E)!Quantification" of" synaptic" area" representing" normalized" Bruchpilot"
positive" signal" detected" in" the" immunostainings" of" the" different" genotypes" and" time/
points"shown"in"A/D’’."Results"are"represented"in"dot/blot"diagrams"showing"all"measured"
and" normalized" values." Bars" represent" mean" and" SDM." Statistical" t/test" results" are"
indicated"with"***"p<0,001,"**"p<"0,01"and"*"p<0,05"for"control"group"comparisons,"and"
###" p<0,001," ##" p<0,01" and" #" p<0,05" for" Aβ42" group" comparisons."When" no" statistical"
significance"is"found"p"value"is"indicated."Scale"bar"is"20μm."
Fig.!R2!No!transcriptional!changes!are!found!in!any!of!the!studied!genotypes.!Histograms"
plotting" mRNA" levels" of" bruchpilot" (A)," liprin" (B)" and" synaptobrevin" (C)" measured" by"
quantitative"RT/PCR"in"15"days/old"adult"brains"of"the"indicated"genotypes"expressed"with"
elavc155/Gal4/TubGal80ts." Results" are" represented"as" fold" induction"with" respect" to"UAS/
lacZ" (control)" group" (red" dotted" line)." Error" bars" represent" SDM." Comparisons" between"
groups"correspond"to"t/test"analysis.!
Fig.! R3! PI3K! prevents! Aβ42<induced! microtubule! dynamics! deficits.! (A)! Schematic"
cartoon" depicting"microtubule" growth" and" shrinking" processes" noting" the" presences" of"
EB1"protein" at" the" plus/end"of" a" growing"microtubule." (B<E)" Still" images" of" live" imaging"
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recordings"for"EB1/GFP"in"ddA"sensory"neurons"of"third"instar"larvae"expressing"UAS/lacZ"
(control),"UAS/PI3KCAAX,"UAS/Aβ42(2x),"and"UAS/PI3KCAAX/UAS/Aβ42(2x)"with"elavc155/Gal4"
driver."(F<I)!Dot/blot"diagrams"showing"EB1/GFP"comets"quantification"of"track"speed"(F),"
track"length"(G),"track"duration"(H),"and"track"density"(I)."Normalized"values"and"SDM"bars"
are"represented"and"statistical"t/test"analysis"is"shown"with"***"p<0,001,"**"p<"0,01"and"*"
p<0,05"for"control"group"comparisons,"and"###"p<0,001,"##"p<0,01"and"#"p<0,05"for"Aβ42"
group"comparisons."When"no"statistical"significance"is"found"p"value"is"indicated."Scale"bar"
is"50μm."
Fig.!R4!Aβ42<induced! locomotion!activity! reduction! is!delayed!by!PI3K!overexpression.!
(A)" Schematic" cartoon" representing" the" three" fly" populations" considered" in" the"
locomotion"analysis."(B<E)"Histograms"showing"standardized"values"of"the"number"of"flies"
climbing" to" the" top"of" the" tube" (blue)," climbing" the" tube"but"not" reaching" the"4cm" line"
(orange),"and"staying"at" the"bottom"of" the" tube" (black)."UAS/lacZ" (control)" (B,F,G),"UAS/
PI3KCAAX" (C,H,I),"UAS/Aβ42(2x)" (D,J,K),"and"UAS/PI3KCAAX/UAS/Aβ42(2x)" (E,L,M)"expression"
with"elavc155/Gal4/TubGal80TS"respectively"corresponds"to"the"indicated"genotypes."(F<M)!
Pie"chart"diagrams"representing"detailed"percent"values"at"15"days" (F,H,J,L)"and"20"days"
(G,I,K,M)."
Fig.! R5! PI3K! expression! increases! lifespan! of! Aβ42! flies.! (A<E)! Survival" curves" for" the"
following" genotypes:" PI3K" (A,E);" Aβ42" (B,D,E);" and" PI3K/Aβ42" (C,D,E)" compared" to" lacZ"
(control)"genotype"(black"lines"in"A/C),"or"compared"to"Aβ42"genotype"(D)"expressing"the"
corresponding" UAS" constructs" with" elavc155/Gal4/TubGal80TS." (E)" Survival" curve"
representing" survival" data" in" all" genotypes." Statistical" analysis" with" Mantel/Cox" test" is"
shown"as"****"p<0,0001.""
Fig.!R6!PI3K!activation!in!human!neurons!prevents!the!cell!survival!reduction!induced!by!
Aβ42." HTSY/5Y" cells" differentiated" (retinoic" acid" 10μM)" and" treated" with" increasing"
concentrations" of" Aβ42" oligomers" (18μg/ml," 36μg/ml" and" 72μg/ml)" for" 48h," and" PTD4/
PI3KAc" peptide" (50μg/ml)" at" different" time/points:" 24" hours" before" Aβ42" oligomers"
(pretreatment),"at"the"same"time"that"Aβ42"oligomers"(co/treatment),"and"24"hours"after"
Aβ42" oligomers" (post/treatment)." Data" from" Cell" Titer" Glo" luminescence" is" shown" as"
percent" viability" and" compared" to" control" values" of" non/treated" cells" (red/dotted" line)."
Error" bars" indicate" SDM." Statistical" significance" is" represented" from" t/test" analysis" with"
***"p<0,001,"**"p<"0,01"and"*"p<0,05."
Fig.!R7!Synaptogenic!proteins,!but!not! canonical!PI3K!effectors,!prevent!Aβ42<induced!
synapse! loss." (A<F)! Representative" confocal" image" examples" of" Bruchpilot"
immunostainings"visualizing"adult"VLM"NMJs"expressing"UAS/lacZ"(control)"(A),"UAS/mTOR"
(B)," UAS/MedeaRNAi" (C)," UAS/Aβ42(2x)" (D)," UAS/mTOR/UAS/Aβ42(2x)" (E)," and" " UAS/
MedeaRNAi/" UAS/Aβ42(2x)" (F)" constructs" with" elavc155/Gal4/TubGal80TS" at" 15" days." (G)!
Quantification" of" synaptic" area" representing" normalized" Bruchpilot" positive" signal"
detected" in" the" immunostainings" of" the" different" genotypes" in" A/F." Results" are"
represented" in" dot/blot" diagrams" showing" all" measured" and" normalized" values." Bars"
represent"mean"and"SDM."Statistical"t/test"results"are" indicated"with"***"p<0,001,"**"p<"
0,01" and" *" p<0,05" for" control" group" comparisons," and" ###" p<0,001," ##" p<0,01" and" #"
p<0,05" for"Aβ42"group"comparisons."When"no" statistical" significance" is" found"p" value" is"
indicated."Scale"bar"is"20μm."
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Fig.! R8! Aβ42<induced! locomotor! decline! is! prevented! by! Medea! knockdown.! (A)!
Schematic" cartoon" representing" the" three" fly" populations" considered" in" the" locomotion"
analysis."(B<F)"Histograms"showing"standardized"values"of"the"number"of"flies"climbing"to"
the"top"of"the"tube"(blue),"climbing"the"tube"but"not"reaching"the"4cm"line"(orange),"and"
staying"at"the"bottom"of"the"tube"(black)."Corresponding"genotypes"are:"UAS/lacZ"(control)"
(B,G,H)," UAS/mTOR" (C,I,J)," UAS/mTOR/UAS/Aβ42(2x)" (D,K)," UAS/MedeaRNAi" (E,L,M)," and""
UAS/MedeaRNAi/" UAS/Aβ42(2x)" (F,N,O)" constructs" expressed" with" elavc155/
Gal4/TubGal80TS."(G<O)!Pie"chart"diagrams"representing"detailed"percent"values"at"15"days"
(G,I,K,L,N)"and"20"days"(H,J,M,O)."
Fig.! R9! Medea! downexpression! blocks! the! Aβ42<induced! lifespan! reduction.! (A<G)!
Survival"curves"for"the"following"genotypes:"UAS/mTOR"(A,G);"UAS/MedeaRNAi"(C,G),"UAS/
Aβ42(2x)" (E,F,G);" UAS/mTOR/UAS/Aβ42(2x)" (B,E,G)," and" " UAS/MedeaRNAi/" UAS/Aβ42(2x)"
(D,F,G);" compared" to" UAS/lacZ" (control)" genotype" (black" lines" in" A/D)," or" compared" to"
Aβ42" genotype" (E/F)." Constructs" are" expressed"with"elavc155/Gal4/TubGal80TS" driver." (G)"
Survival"curve"representing"survival"data"in"all"genotypes."Statistical"analysis"with"Mantel/
Cox"test"is"shown"as"****"p<0,0001."
Fig.! R10! PI3K! activation! increases! Aβ42! levels! without! affecting! transcription.! (A<D)!
Representative"confocal" image"examples"of"Aβ"(white)" immunostainings"visualizing"adult"
brains" expressing" UAS/lacZ" (control)" (A)," UAS/PI3Kcaax" (B)," UAS/Aβ42(2x)" (C)," and" UAS/
PI3KCAAX/UAS/Aβ42(2x)" (D)" constructs" at" 15" with" elavc155/Gal4/TubGal80TS." (E)!
Representative" immunoblot" indicating" Aβ" levels" in" control," Aβ42" and" PI3K/Aβ42" adult"
heads"corresponding"to"the"same"time/point"and"genotypes"used"for"immunostainings"(A/
D)."Histogram" represents"mean"Aβ" levels" quantified" and" normalized" to" tubulin" of" three"
independent"Western/blots."Error"bars"indicate"SDM."(F)"Histograms"plotting"mRNA"levels"
of" Aβ! measured" by" quantitative" RT/PCR" in" 15" days/old" adult" brains" of" the" indicated"
genotypes" expressed" with" elavc155/Gal4/TubGal80ts." Results" are" represented" as" fold"
induction"with" respect" to"Aβ42"group."Error"bars" represent"SDM."Comparisons"between"
groups"correspond"to"t/test"analysis."
Fig.! R11! PI3K! overexpression! increases! Aβ42! insoluble! fraction.! (A)! Schematic" cartoon"
showing" the" different" Aβ" conformers" generated" upon" β" and" γ" secretases" processing" of"
APP." Aggregates" range" from" soluble" to" insoluble" and" differ" in" toxicity" from" less" toxic"
species"(green)"to"more"toxic"assemblies"(orange)."(B<C’)!Representative"confocal" images"
of" thioflavin" stainings" visualizing" 7" days" (B,C)" and" 15" days" (B’," C’)" adult" brains" of" the"
following" genotypes:" UAS/Aβ42(2x)" (B/B’)," and" UAS/PI3KCAAX/UAS/Aβ42(2x)" (C,C’)" with"
elavc155/Gal4/TubGal80TS" driver." (D)" Histograms" representing" thioflavin" staining"
quantification."Data"are"shown"as"mean"Aβ"levels"normalized"with"respect"to"Aβ42"group."
Error"bars" represent"SDM."Comparisons"between"groups"correspond"to"t/test"analysis."*"
p<0,05.! (E)! Representative" immunoblot" indicating" insoluble" Aβ" levels" in" control," PI3K,"
Aβ42" and" PI3K/Aβ42" adult" heads" of" 15" days/old" flies." Histogram" represents" mean" Aβ"
levels" quantified" and" normalized" to" tubulin" of" three" independent" Western/blots." Error"
bars"indicate"SDM."
Fig.!R12!PI3K<induced!Aβ42!aggregation!changes!are!reproduced!in!human!neurons.!(A)!
Schematic" cartoon" representing" the" experimental" design" in" HT/SY5Y" cells" differentiated"
(retinoic"acid"10μM)"and"treated"with"Aβ42"oligomers"(36μg/ml)"and"PTD4/PI3KAc"peptide"
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(50μg/ml)" for" 48h." (B<D)!Histograms" representing"percent" values"of" number"of" deposits"
(B),"total"deposit"area"(C)"and"deposit"size"distribution"(D)"of"PI3K/Aβ42"and"Aβ42"treated"
cells."Statistical" t/test" results"are" indicated"with"*"p<0,05." (E<H’)!Representative"confocal"
images" showing"Aβ" (green)"and"DAPI" (magenta)" immunostainings."Merged" (E/H)"and"Aβ"
signal"(E’/H’)"images"represent"Aβ"deposits"for"the"indicated"treatments."
Fig.!R13!PI3K<induced!changes!in!Aβ42!aggregation!can!be!reproduced!outside!of!cells.!
(A)! Schematic" cartoon" representing" the" experimental" design" in" HT/SY5Y" cells"
differentiated"(retinoic"acid"10μM)"and"treated"with"Aβ42"oligomers"(36μg/ml)"and"PTD4/
PI3KAc"peptide"(50μg/ml)"at"different"time/points."(B<E)!Histograms"representing"percent"
values"of"number"of"deposits"(B),"total"deposit"area"(C),"number"of"deposits/"deposit"area"
ratio"(D),"and"deposit"size"distribution"(E)"of"Aβ42"and"PI3K/Aβ42"treated"cells."
Fig.! R14! pSer<Aβ42! increases! following! PI3K! overexpression.! (A)! Scheme" representing"
Aβ42"sequence"and"the"Net/Phos"predicted"residues"for"potential"phosphorylations."(B<E’)!
Representative"confocal"images"of!p/serine"(green)"and"DAPI"(magenta)"immunostainings"
visualizing"15"days/old"adult"brains"of" the" following"genotypes:"UAS/lacZ" (control)" (B,B’),"
UAS/PI3Kcaax"(C,C’),"UAS/Aβ42(2x)"(D,D’),"and"UAS/PI3KCAAX/UAS/Aβ42(2x)"(E,E’)"constructs"
with" elavc155/Gal4/TubGal80TS" driver." (F<I’)!Representative" confocal" images" of!p/tyrosine"
(green)" and"DAPI" (magenta)" immunostainings" visualizing"15"days/old" adult"brains"of" the"
following" genotypes:" UAS/lacZ" (control)" (F,F’)," UAS/PI3Kcaax" (G,G’)," UAS/Aβ42(2x)" (H,H’),"
and"UAS/PI3KCAAX/UAS/Aβ42(2x)"(I,I’)"constructs"with"elavc155/Gal4/TubGal80TS"driver."Scale"
bar"is"10μm."
Fig.! R15! PI3K! specifically! triggers! Ser26<Aβ42! phosphorylation.! (A<B’’’)! Representative"
confocal" images" of! p.Ser26/Aβ42" (green)," p.Ser8/Aβ42" (red)" and" DAPI" (magenta)"
immunostainings" visualizing" 15" days/old" adult" brains" of" the" following" genotypes:" UAS/"
UAS/Aβ42(2x)" (A/A’’’)," and" UAS/PI3KCAAX/UAS/Aβ42(2x)" (B/B’’’)" constructs" with" elavc155/
Gal4/TubGal80TS"driver." (A´/A’’’,"B/B’’’)" show"magnified" images" for"both"genotypes"Scale"
bar"is"50μm"in"(B)"and"10μm"in"(B’)."
Fig.! R16! Aβ42<induced! inflated! abdomen! phenotype! is! prevented! by! PI3K!
overexpression.! (A)! Representative" images" of" 15" days/old" adult" flies" expressing" the"
following" UAS" constructs:" UAS/lacZ" (control)," UAS/Aβ42(2x)," UAS/PI3KCAAX" and" UAS/
PI3KCAAX/UAS/Aβ42(2x)"with"elavc155/Gal4/TubGal80TS"driver."(B)"Lateral"views"of"Aβ42"and"
PI3K/Aβ42" genotypes." (C)" Lateral" views" of" head" and" proboscis" of" Aβ42" and" PI3K/Aβ42"
genotypes"
Fig.!R17!The!nervous!system!enhancer!elav!is!transiently!active!in!epithelial!cells!of!the!
wing!disc.!(A<B’)!Representative"images"of"G/TRACE"pattern"from"elav"enhancer"in" larval"
brains" (A,A’)" and" wing" discs" (B,B’)." (C<D’)" Still" images" of" G/TRACE" pattern" from" early"
developmental"wing"disc"stages"of" first" instar" (C,C’)"and"second" instar" (D,D’)" larvae.! (E<I)"
Representative"images"of"G/TRACE"pattern"of"third"instar"larvae"wing"discs"of"elav/Gal4"in"
the"third"chromosome"(E/F)"in"particular"left"(E)"and"right"(F);"and"elav/Gal4"in"the"second"
chromosome"(H/I)"in"particular"left"(H"and"right"(I)."(G)"Overlapped"images"of"GFP/positive"
cells"from"left"(red)"and"right"(green)"wing"discs"of"elav/Gal4"in"the"third"chromosome."(J)"
Quantification" (n=5)"of"G/TRACE"pattern"of"elav"enhancer"comparing" two"different"elav/
Gal4" insertions," chromosome" III" (E/F)" and" chromosome" II" (H/I)." (K<L’)! Representative"
98"
confocal" images" of" elav" G/TRACE" pattern" (K,L)" and" Elav" immunostaining" (K’,L’)" in" larval"
brain"(K,K’)"and"in"wing"discs"(L,L’)."Statistical"t/test"is"represented"with"*p<0,05."Scale"bar"
is"50µm.!
Fig.!R18!Toll26!enhancer!(D42<Gal4)!is!transiently!activated!in!wing!imaginal!discs!during!
the! first! 12h! after! egg<laying.! (A)! Schematic" representation" of" experimental" design."
Crosses"were"set"and"maintained"24"hours"at"25°C."Then,"first"instar"larvae"were"placed"at"
17°C" (expression" system"OFF)" or" at" 29°C" (expression" system"ON)" for" the" indicated" time"
points:" Always" at" 17°C" “OFF”," 48h," 24h" or" 12h" at" 17°C" or" always" at" 29°C" “ON”." (B<H)!
Representative" images" of" temporal" expression" experiments" in"D428Gal4>G8TRACE>elav8
Gal80TS"brain" (B,C))"and"wing"discs" (D/H)"maintained"at"17°C"“OFF”" (Gal4"silenced),"48h,"
24h"or"12h"OFF"or"maintained"at"29°C"“ON”"(Gal4"active)."(I)"Quantification"(n=5)"of"GFP/
positive"cells"per"time"point."Statistical"t/test"analysis"is"represented"with""*"p<0,05.!
Fig.! R19! Toll26! gene! product! is! not! necessary! for! wing! disc! development.! (A<F)!
Representative"images"of"Caspase"3"activation"(green)"(C3)"and"Wingless"expression"(red)"
and" DAPI" (blue)" immunostainings" in" wild" type" (A/B)," D42/Gal4>Toll6RNAi" (C/D)" and"D428
Gal4>Bsk" " (E/F)" genotypes." (G<I)" Representative" images" of" resulting" adult" wings" in" wild"
type"(G),"D42/Gal4>Toll6RNAi"(H),"and"D428Gal4>Bsk"(I)"genotypes.!
Fig.! R20! Adult! wing! defects! in! Aβ42! flies! are! restored! by! PI3K! overexpression.!
Representative" images"of"adult" fly"wings"of" the" following"genotypes:"UAS/lacZ" (control),"
UAS/PI3KCAAX,"UAS/Aβ42(2x)"and"UAS/PI3KCAAX/UAS/Aβ42(2x)"with"D42/Gal4"driver.!
Fig.!R21!PI3K!overexpression! reduces!Aβ42<induced!apoptosis! in!epithelial! cells!of! the!
wing! disc.! (A<D’)! Representative" confocal" images" of" caspase/3" (A’/B’)" and" phospho/
histone/3"(C’/D’)"and"DAPI"(magenta)" immunostainings"from"third"instar" larval"wing"discs"
expressing" UAS/Aβ42(2x)" and" UAS/PI3KCAAX/Aβ42(2x)" with" engrailed/Gal4/UAS/GFPnls"
driver"that"expresses"GFP"in"the"affected"nuclei"(green)"(A/B,C/D)."
Fig.! R22! PI3K! overexpression! restores! Wnt! signaling! impairment! caused! by! Aβ42! in!
epithelial!cells!of!the!wing!disc.!(A<D’)!Representative"confocal"images"of"wingless"(A’/B’)"
and"armadillo" (C’/D’)" and"DAPI" (magenta)" immunostainings" from" third" instar" larval"wing"
discs" expressing" UAS/Aβ42(2x)" and" UAS/PI3KCAAX/Aβ42(2x)" with" engrailed/Gal4/UAS/
GFPnls"driver,"that"expresses"GFP"in"the"affected"nuclei"(green)"(A/B,C/D)."
"
!
Fig.!D1!APP!described!mutations! in!Aβ!region.!Aβ"aminoacidic"sequence"representation"
showing"the"sites"for"β"and"γ"secretase"cleavage"(red"arrows)."Mutations"in"APP"inside"the"
Aβ" region" indicate" changes" that" lead" to" an" increase" in"Aβ"production" (blue),"modify"Aβ"
biophysical"characteristics"(black),"or"alter"Aβ"spectrum"(green)"(Benilova"et"al,"2012)."
"
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